NewTimeSpace

HK Newly Listed Stocks Weekly Tracker: AUX ELECTRIC's 1.3 Billion-Share Lock-up Expiry Lands Softly; UNISOUND Leads Rebound in Newer Listings - 20260904

Fri, 04 Sep 2026 14:05:23 GMT

During the week (August 31 - September 4), the market for recently listed stocks was mixed: names that had fallen sharply on earlier lock-up expiries, such as UNISOUND and MININGLAMP-W, rebounded, while SHEIN-W and MECH-MIND ROBOTICS, which listed on September 1, both fell more than 21% in their debut week. AUX ELECTRIC released 1.301 billion shares from lock-up this week, the largest single-issuer release recently, yet fell only 5.05% over the week, a relatively mild impact. On liquidity, MINIMAX-W's average daily turnover overtook Z.AI to take the top spot. DEEPZERO's cumulative gain widened to 1,599%, keeping it in the lead; ZG GROUP-W regained the deepest discount-to-offering-price position. Few lock-up expiries are scheduled next week, all of small size.

I. Weekly Changes:UNISOUND Leads Gains; Two New Listings Fell over 20% in Debut Week

Metric	Stock Code	Stock Name	Listing Date	Weekly Change (%)
op Weekly Gainer 1	9678.HK	UNISOUND	2025-06-30	32.31
Top Weekly Gainer 2	2718.HK	MININGLAMP-W	2025-11-03	25.06
Top Weekly Gainer 3	7688.HK	TOPNC	2026-05-20	23.61
Top Weekly Gainer 4	1879.HK	XIZHI TECH-P	2026-04-28	21.05
Top Weekly Gainer 5	0100.HK	MINIMAX-W	2026-01-09	20.31
Bottom Weekly Loser 5	6880.HK	MOMENTA-W	2026-07-08	-19.53
Bottom Weekly Loser 4	2597.HK	XUNZHONG	2025-07-09	-20.26
Bottom Weekly Loser 3	9615.HK	MECH-MIND ROBOTICS	2026-09-01	-21.34
Bottom Weekly Loser 2	0625.HK	SHEIN-W	2026-09-01	-21.36
Bottom Weekly Loser 1	2652.HK	CF PHARMTECH	2025-10-08	-24.19

The best-performing recently listed stocks this week included UNISOUND (+32.31%), MININGLAMP-W (+25.06%), TOPNC (+23.61%), XIZHI TECH-P (+21.05%) and MINIMAX-W (+20.31%). UNISOUND and MININGLAMP-W, which had fallen sharply on lock-up expiries in late June and late July respectively, both recorded notable gains this week. On the downside, CF PHARMTECH fell 24.19% this week, the biggest weekly drop among recently listed stocks; SHEIN-W and MECH-MIND ROBOTICS declined 21.36% and 21.34% respectively, both having listed on September 1 and retreating considerably in their debut week. XUNZHONG fell 20.26% and MOMENTA-W declined 19.53%. Of the five biggest weekly losers, SHEIN-W and MECH-MIND ROBOTICS were newly listed names, while the other three had no recent lock-up expiries.

II. Review of Lock-up Expiries This Week:AUX ELECTRIC Released 1.3 Billion Shares and Fell 5.05% on the Week

No.	Code	Name	Listing Date	Lock-up Expiry Date	Shares Unlocked (10,000 shares)	Weekly Change (%)
1	2580.HK	AUX ELECTRIC	2025-09-02	2026-09-02	130,092.13	-5.05

Only one recently listed stock had a lock-up expiry this week. AUX ELECTRIC released 1,300,921,300 shares on September 2, the largest single-issuer release recently, with the stock falling 5.05% over the week. Relative to the size of the release, the decline was mild, and the more than 30% single-week drops seen for some names after earlier expiries did not recur.

III. Next Week's Lock-up Expiry Preview: Three Stocks, All of Small Size

No.	Code	Name	Listing Date	Lock-up Expiry Date	Shares Unlocked (10,000 shares)
1	3268.HK	MEIG	2026-03-10	2026-09-10	1,588.74
2	2715.HK	ESTUN	2026-03-09	2026-09-09	3,404.86
3	2692.HK	ZHAOWEI	2026-03-09	2026-09-09	914.07

Three recently listed stocks will see lock-up expiries next week. ESTUN will release 34,048,600 shares on September 9, MEIG 15,887,400 shares on September 10 and ZHAOWEI 9,140,700 shares on September 9. All three releases are below 50 million shares, clearly smaller than AUX ELECTRIC's release this week, so overall lock-up pressure next week is light.

IV. Liquidity Observations: MINIMAX-W's Average Daily Turnover Overtakes Z.AI

Metric	Stock Code	Stock Name	Listing Date	Average Daily Turnover (HKD 10,000)	Average Daily Turnover Rate (%)
Most Liquid 1	0100.HK	MINIMAX-W	2026-01-09	716,762.0816	7.5594
Most Liquid 2	2513.HK	Z.AI	2026-01-08	674,414.8556	2.4335
Most Liquid 3	3308.HK	ZJ INNOLIGHT	2026-07-30	171,304.7661	2.6626
Most Liquid 4	3750.HK	CATL	2025-05-20	147,609.8472	1.1669
Most Liquid 5	2259.HK	ZIJIN GOLD INTL	2025-09-30	132,109.6118	0.3204
Least Liquid 5	2619.HK	XJ ELECTRICS	2025-06-25	2.9039	0.0352
Least Liquid 4	8549.HK	GOLDEN LEAF INT	2025-10-10	2.7197	0.0335
Least Liquid 3	8629.HK	SYNTRUST GK	2024-09-06	2.4072	0.0262
Least Liquid 2	2519.HK	AUGROUP	2024-11-08	1.9890	0.0012
Least Liquid 1	2613.HK	CONTIOCEAN	2025-01-09	1.0904	0.0009

The top of the liquidity rankings among recently listed stocks changed this week. MINIMAX-W's average daily turnover surged to HKD 7.168 billion from HKD 3.425 billion last week, jumping to first place with an average daily turnover rate of 7.56%. Z.AI's average daily turnover recovered to HKD 6.744 billion from HKD 4.672 billion last week but slipped to second, with an average daily turnover rate of 2.43%. ZJ INNOLIGHT averaged HKD 1.713 billion in daily turnover, CATL HKD 1.476 billion and ZIJIN GOLD INTL HKD 1.321 billion, ranking third to fifth. Among the least liquid names, CONTIOCEAN averaged HKD 10,904 in daily turnover, AUGROUP HKD 19,890, SYNTRUST GK HKD 24,072, GOLDEN LEAF INT HKD 27,197 and XJ ELECTRICS HKD 29,039. The bottom ranks were broadly unchanged from last week.

V. Deviation from IPO Price: DEEPZERO Extends Cumulative Gain to 1,599%; ZG GROUP-W Back to Deepest Discount

Metric	Stock Code	Stock Name	Listing Date	IPO Price (HKD)	Closing Price (HKD)	Deviation (%)
Largest Premium 1	2723.HK	DEEPZERO	2026-05-27	55.50	943.00	1599.10
Largest Premium 2	2797.HK	QIYUNSHAN FOOD	2026-07-09	8.00	86.50	981.25
Largest Premium 3	2513.HK	Z.AI	2026-01-08	116.20	1075.00	825.13
Largest Premium 4	0805.HK	NEW GONOW RV	2025-01-13	1.27	8.30	553.54
Largest Premium 5	2687.HK	ABLE DIGITAL	2025-12-08	67.50	365.20	441.04
Deepest Discount 5	2592.HK	CLOUDBREAK-B	2025-07-03	10.10	1.18	-88.32
Deepest Discount 4	2570.HK	REFIRE	2024-12-06	147.00	14.01	-90.47
Deepest Discount 3	2525.HK	HESAI-W	2025-09-16	212.80	18.19	-91.45
Deepest Discount 2	3881.HK	CIDI	2025-12-19	263.00	19.12	-92.73
Deepest Discount 1	6676.HK	ZG GROUP-W	2025-03-10	10.00	0.70	-93.05

Measured against its offering price, DEEPZERO closed at HKD 943.00, a deviation of 1,599.10% from its IPO price of HKD 55.50, ranking first among recently listed stocks for a second consecutive week, with the deviation widening further from 1,320.72% last week. QIYUNSHAN FOOD closed at HKD 86.50, a deviation of 981.25%, staying second. Z.AI closed at HKD 1,075.00, a deviation of 825.13%, ranking third. NEW GONOW RV (553.54%) and ABLE DIGITAL (441.04%) entered the top five this week. On the discount side, ZG GROUP-W closed at HKD 0.70, a deviation of -93.05%, regaining the title of the most deeply discounted recently listed stock. CIDI deviated -92.73%, HESAI-W -91.45%, REFIRE -90.47% and CLOUDBREAK-B -88.32%.

Matters to Watch Next Week

1. ESTUN, MEIG and ZHAOWEI will see lock-up expiries next week, each releasing no more than 35 million shares, implying light overall lock-up pressure.

2. MINIMAX-W's average daily turnover rose to HKD 7.168 billion this week, overtaking Z.AI to become the most liquid; Z.AI's average daily turnover recovered to HKD 6.744 billion, though still below its July high.

3. SHEIN-W and MECH-MIND ROBOTICS, both listed on September 1, fell 21.36% and 21.34% respectively in their debut week, the only two new listings among the week's five biggest losers, underscoring the high volatility of recently listed stocks in their early trading days.

Note: This report defines "newly listed stocks" as HK-listed targets listed for less than 24 months.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Going Global Weekly Report: Pharma Firms Sealed Licensing Deals at a Fast Pace as Semiconductors and E-Commerce Accelerate toward HK Listings - 20260904

Fri, 04 Sep 2026 11:30:57 GMT

Outbound M&A

1.MAN WAH HLDGS (01999.HK): On August 31, announced the acquisition of 7,684,126 shares of UK-based DFS, representing approximately 3.26% of DFS's issued shares, from Man Wah Wong Family Investment Limited for a consideration of GBP 12.4713 million (approximately HKD 132 million), lifting its stake to approximately 8.58% upon completion. DFS is a UK upholstered furniture retailer listed on the London Stock Exchange, which recorded revenue of GBP 1.03 billion in FY2025.

Outbound Partnerships

1.HUTCHMED (00013.HK): On September 3, announced that its subsidiary had entered into an exclusive development and licensing agreement with a GSK affiliate for HMPL-A830, a KRAS-EGFR antibody-targeted conjugate drug, granting rights to develop and commercialize the drug globally excluding Mainland China, Hong Kong SAR, Macao SAR and the Taiwan region, for an upfront payment of USD 110 million and development, regulatory and commercial milestone payments totalling up to USD 1.295 billion, plus royalties based on net sales; a global Phase I clinical trial is expected to commence in the second half of 2026.

2.SBP GROUP (01177.HK): On August 31, announced that its subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. had entered into an exclusive licensing and supply agreement with Cipla for TQB2102, a HER2 bispecific antibody-drug conjugate, under which Cipla is licensed to develop and commercialize the drug in India, South Africa and five other emerging markets, entitling the group to up to USD 123 million in milestone payments plus double-digit royalties. This is the second regional licensing collaboration concluded for TQB2102.

3.KEYMED BIO-B (02162.HK): On September 2, signed an exclusive licensing agreement with Aeira Pte. Ltd. covering registration and commercialization of its self-developed IL-4Rαmonoclonal antibody, stapokibart injection (Kangyueda), in 18 countries and regions, including 11 Southeast Asian countries, 5 Central Asian countries and the Hong Kong and Macao SARs. The company will receive upfront payments, milestone payments and high-double-digit sales-based royalties.

4.PEGBIO CO-B (02565.HK): On September 2, entered into a material transfer agreement with South Korea's SN BioScience to apply its SNA long-acting delivery platform to three peptide drug candidates for metabolic diseases, including APGP6, for joint long-acting development studies.

Outbound Financing

1.SHEIN-W (00625.HK): On August 31, announced the results of its global offering at a final offer price of HKD 48.56 per share, with 279,992,500 Class B shares offered in total, raising approximately HKD 13.596 billion in gross proceeds and approximately HKD 13.214 billion in net proceeds; the shares commenced trading on The Stock Exchange of Hong Kong on September 1.

2.ANJI TECHNOLOGY (688019.SH): On September 3, submitted an application to HKEX for the issuance and listing of H shares.

3.AMLOGIC (688099.SH): On September 1, its H-share issuance received filing with the China Securities Regulatory Commission (CSRC), with a proposed issuance of no more than 53,815,500 H shares.

4.LONGSYS (09976.HK): On September 4, fixed the offer price for its H-share global offering at HKD 236.00 per share, offering 26,077,800 H shares, with listing expected on September 8.

Regulation and Compliance

1.SBP GROUP (01177.HK): On September 3, announced that TQB6426, a national Class 1 innovative drug and a GPC3-targeting antibody-drug conjugate independently developed by its subsidiary Chia Tai Tianqing, had received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for advanced malignant tumors. GPC3 is highly expressed in hepatocellular carcinoma, and no GPC3-targeting ADC has been approved for marketing worldwide.

Overseas Orders and Contract Wins

1.HONGHUA GROUP (00196.HK): On September 2, announced that its subsidiary Sichuan Honghua Petroleum Equipment Co., Ltd. had signed drilling rig sales agreements with a Middle East customer aggregating RMB 600 million, under which it will supply several large drilling rigs equipped with self-developed intelligent equipment, including automated tools and the Opera smart drilling system.

Overseas Operating Data

1.BYD COMPANY (01211.HK): On September 1, disclosed August sales of 440,300 new energy vehicles, of which 189,500 were exports.

2.GEELY AUTO (00175.HK): On September 1, disclosed total sales of 270,200 units in August, up 8% year on year, with ZEEKR-brand sales up 110% year on year and exports up 205% year on year.

NewTimeSpace Overseas Watch

This week's overseas hotspots centered on two fronts: pharmaceutical asset licensing and Hong Kong listings. Drugmakers are out-licensing self-developed pipelines through regional or even global exclusive agreements, with deals generally structured as upfront payments plus milestone payments and sales-based royalties, and licensed territories extending from emerging markets such as India and South Africa to Southeast Asia, Central Asia and global scope, while differentiated targets such as GPC3 ADCs are beginning to draw collaborations with multinational drugmakers. On the financing front, cross-border e-commerce and A-share semiconductor and memory companies are concentrating on or advancing H-share listings in Hong Kong, with both single-project fundraising scale and the density of H-share offerings rising in tandem. The observations show that pharma going global is evolving from one-off clinical approvals toward scaled global rights licensing, equipment manufacturers are locking in incremental demand in markets such as the Middle East through large orders, and automakers' exports continue to grow, as the going-global model shifts from product exports toward a balance of rights deals and capital market operations.

This article is for information organization only and does not constitute any investment advice.

HK Stock Connect Daily Report: PHANCY Surged Nearly 15%; Hang Seng Index Quarterly Review Effective Today, Goldman Sachs Expects USD 870 Million of Passive Inflows into Tech Hardware - 20260904

Fri, 04 Sep 2026 11:01:21 GMT

I. Market Overview

On September 4, all three major Hong Kong indices advanced across the board. The Hang Seng Index rose 1.74% to 25,650.87 points, the Hang Seng TECH Index gained 2.27%, and the Hang Seng China Enterprises Index climbed 2.02%. Full-day turnover reached HKD 276.857 billion, expanding notably from the previous session.

On the trading floor, AI application plays led the gains: PHANCY (06682) jumped 14.66% and MARKETINGFORCE (02556) surged 13.52%, as OpenAI's release of GPT-6 Astra shifted market pricing logic from compute supply to application monetization. Mainland property developers extended their gains, with SUNAC (01918) up 14.29% and LONGFOR GROUP (00960) up 8.4%, following the "828" property policy package that systematically restructures the industry's regulatory framework. Hog-related plays strengthened, with MUYUAN (02714) up 9.21% as the national average hog price rebounded nearly 17% from its June trough. Innovative drug plays gained broadly, with AKESO (09926) up 11.45%. Semiconductor stocks plunged against the trend: HUA HONG GRACE (01347) fell 8.4%, and GENSCRIPT BIO (01548) dropped 13.33% on news of its proposed spin-off of Probio Technology Limited. SHEIN-W (00625) slid 9.19% to extend its new lows.

Southbound capital recorded net selling of HKD 10 billion during the day, with the Shanghai leg of southbound Stock Connect seeing net selling of HKD 4.708 billion and the Shenzhen leg net selling of HKD 5.313 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainer 1	06682.HK	PHANCY	14.66	30.98	6.19
Gainer 2	01918.HK	SUNAC	14.29	0.64	3.66
Gainer 3	02556.HK	MARKETINGFORCE	13.52	67.60	9.15
Gainer 4	09926.HK	AKESO	11.45	101.20	35.52
Gainer 5	00136.HK	CHINA RUYI	11.43	1.37	3.07
Loser 5	02575.HK	XUANZHUBIO-B	-6.21	10.43	0.47
Loser 4	01316.HK	NEXTEER	-6.45	4.94	1.08
Loser 3	02652.HK	CF PHARMTECH	-6.78	11.00	0.36
Loser 2	01347.HK	HUA HONG GRACE	-8.43	109.70	62.61
Loser 1	01548.HK	GENSCRIPT BIO	-13.33	31.46	32.05

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	00100.HK	MINIMAX-W	65.21	9.48	1.80
2	00700.HK	TENCENT	47.47	-21.02	2.26
3	00981.HK	SMIC	45.20	-9.04	-1.25
4	02513.HK	Z.AI	41.84	6.07	-2.98
5	01347.HK	HUA HONG GRACE	37.72	-7.53	-8.43
6	01888.HK	KB LAMINATES	36.50	1.64	-5.27
7	09988.HK	ALIBABA-W	29.26	1.38	2.42
8	01548.HK	GENSCRIPT BIO	27.39	-8.24	-13.33
9	09926.HK	AKESO	26.90	-8.32	11.45
10	06869.HK	YOFC	15.85	-1.73	-2.80

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainer 1	520790	CIB CSI HK Equities Internet ETF	4.01	0.13
Gainer 2	159568	Bosera CSI HK Equities Internet ETF	3.39	0.83
Gainer 3	520740	HuaAn CSI HK Equities Internet ETF	3.38	0.05
Gainer 4	159040	Penghua CSI HK Equities Internet ETF	3.37	0.09
Gainer 5	159170	Maxwealth CSI HK Equities Internet ETF	3.29	0.31
Loser 5	159137	Hwabao CSI HK Equities Health Care Theme ETF	-1.73	0.67
Loser 4	158003	Harvest CSI HK Equities Health Care Theme ETF	-1.78	0.28
Loser 3	520850	E Fund CSI HK Equities Health Care Theme ETF	-1.98	0.34
Loser 2	159366	Maxwealth CSI HK Equities Health Care Theme ETF	-2.19	5.15
Loser 1	520510	ChinaAMC CSI HK Equities Health Care Theme ETF	-2.90	7.04

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	513310	Huatai-PB CSI KRX China-Korea Semiconductor ETF (QDII)	CSI China-Korea Semiconductor Index	68.64	60.04	0.11
2	513090	E Fund CSI Hong Kong Securities Investment Theme ETF	CSI Hong Kong Securities Investment Theme Index	57.42	30.73	1.92
3	513120	GF CSI HK Innovative Drugs Industry ETF (QDII)	CNI HK Equities Innovative Drugs Index	57.19	23.03	-0.68
4	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	27.21	7.41	3.24
5	513130	Huatai-PB CSOP Hang Seng Technology Index ETF (QDII)	Hang Seng TECH Index	25.09	7.65	1.62
6	513180	ChinaAMC Hang Seng Technology ETF (QDII)	Hang Seng TECH Index	23.71	5.92	1.59
7	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	18.57	8.08	0.81
8	513330	ChinaAMC Hang Seng Internet Technology Industry ETF (QDII)	Hang Seng Internet Technology Industry Index	18.09	6.96	2.50
9	513050	E Fund CSI Overseas China Internet 50 ETF	CSI Overseas China Internet 50 Index	17.51	4.79	2.03
10	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index	14.88	67.39	0.31

IV. Industry and Corporate Updates

1. Hang Seng Index quarterly review effective today; Goldman Sachs sees USD 870 million passive inflows into tech hardware and semiconductors

On September 4, the quarterly review of the Hang Seng Index family was formally implemented, with all changes effective after today's market close and new constituents to be included in index operations from September 7. The Hang Seng Index added HUA HONG GRACE (01347.HK) and WEICHAI POWER (02338.HK); the Hang Seng TECH Index added ILUVATAR COREX (09903.HK) and removed TONGCHENGTRAVEL (00780.HK); and constituents of the Hang Seng Composite Index increased from 534 to 580. Goldman Sachs estimates the review will generate over USD 7.2 billion in total two-way passive fund flows, with tech hardware and semiconductors expected to record the largest passive inflows of approximately USD 870 million.

2. GENSCRIPT BIO applies to spin off and separately list Probio Technology Limited on HKEX Main Board

On September 4, GENSCRIPT BIO (01548.HK) announced a proposal to spin off and separately list Probio Technology Limited (ProBio), an indirect non-wholly-owned subsidiary that operates the group's biologics and advanced therapy CDMO services, on the Main Board of the Stock Exchange of Hong Kong. The company has submitted an application to the Stock Exchange, and the Listing Committee confirmed on August 14, 2026 that the company may proceed with the proposed spin-off. Upon completion of the spin-off, GENSCRIPT BIO will continue to hold a controlling interest in ProBio, whose financial results will continue to be consolidated into the group's financial statements. GENSCRIPT BIO is a Stock Connect constituent.

3. STAR SHINE HLDG added to Hang Seng Composite Index and swung to profit in H1, with Stock Connect inclusion in prospect

On September 4, STAR SHINE HLDG (01440.HK), which was previously added to the Hang Seng Composite Index, will see the change implemented after today's market close and take effect on September 7. The company posted H1 revenue of RMB 163 million and profit attributable to owners of the company of RMB 24.249 million, versus a loss of RMB 22.511 million in the same period last year, swinging to profitability year on year. Following its inclusion in the Hang Seng Composite Index, STAR SHINE HLDG is expected to become a Stock Connect constituent in tandem.

4. LONGSYS fixes H-share offer price at HKD 236, listing expected September 8

On September 4, semiconductor memory maker LONGSYS (09976.HK) announced that the offer price for its global offering of H shares had been fixed at HKD 236.00 per share. The company plans to offer 26,077,800 H shares globally in board lots of 50 shares, with the H shares expected to commence trading on the Main Board of the Stock Exchange at 9:00 a.m. on September 8, 2026.

5. UDI's IPO subscription closes with margin financing oversubscribed 94.79 times; SENSETIME and 58 Group subsidiaries join as cornerstone investors

On September 4, the IPO subscription of Excelland Robotics (Wuxi) Co. Ltd. (03231.HK), a delivery and cleaning robot company, formally closed, recording HKD 4.214 billion in margin financing subscriptions and oversubscription of 94.79 times against the public fundraising amount of HKD 43.99 million. The company plans to offer 45 million H shares globally at an offer price range of HKD 14.45 to 19.55 per share, with listing expected on September 9. The IPO has brought in SensePower Management Limited, an indirect wholly-owned subsidiary of SENSETIME-W (00020.HK), and CYGG Holding Limited, a wholly-owned subsidiary of the 58 Group, as cornerstone investors.

V. Market Notes

Eligible securities list adjustment announcement

No recent announcements.

Trading calendar

No approaching market closure days.

TOYA receives CSRC supplementary information request on overseas listing filing, covering shareholding entrustment, controlling shareholder title disputes and equity incentives

Fri, 04 Sep 2026 10:00:01 GMT

NewTimeSpace News: Guangdong TOYA Technology Co., Ltd., in the course of its filing for overseas listing and issuance and the "full circulation" of domestic unlisted shares, has received a supplementary information request from the China Securities Regulatory Commission (CSRC), requiring supplementary explanations on six matters, with lawyers engaged to conduct verification and issue clear legal opinions.

The matters include: (i) explaining the pricing basis of each historical capital increase and equity transfer of the issuer, whether capital contributions have been fully paid, whether there are any circumstances of failure to perform capital contribution obligations, withdrawal of capital or defects in the method of capital contribution, and issuing a clear concluding opinion on whether each historical change in equity is lawful and compliant.

(ii) Listing the names of both parties to the shareholding entrustment arrangements in the Company's history, the entrusted shareholding ratios, the commencement and termination dates of the entrustment, and the methods of unwinding the entrustment; explaining, in light of the positions held by the entrusted parties during the entrustment period and in accordance with the relevant provisions of the Guidelines for the Application of Regulatory Rules - Overseas Issuance and Listing Type 2, the reasons for the formation of the shareholding entrustment, its evolution, lawfulness and compliance, whether any disputes or potential disputes exist, and whether the entrusted parties during the entrustment period constitute subjects prohibited by laws and regulations from holding shares (including whether they breached non-competition provisions); and explaining, in light of the above and in accordance with Article 8 of the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies, whether the shares held by the controlling shareholder are subject to any material title disputes.

(iii) Explaining the specific performance of regulatory procedures for overseas investment and foreign exchange registration in respect of the establishment of overseas subsidiaries, with a concluding opinion on compliance. (iv) Explaining the progress of the state-owned shareholders' performance of state-owned share marking and other state-owned assets management procedures, and the basis for determining the authority responsible for state-owned share marking. (v) Explaining whether the participants in the employee equity incentive plans (including the equity incentive involving shares released and granted to specific employees in 2020) are employees of the Company, the specific composition and positions of the participants, whether they have any relationship with the issuer's other shareholders, directors, supervisors or senior management, and the pricing basis, with a clear concluding opinion on whether the implemented equity incentive plans are lawful and compliant and free of benefit transfer.

(vi) Explaining whether the shares held by shareholders proposed to participate in the "full circulation" are subject to any pledge, freezing or other defects in title.

GLB receives CSRC supplementary information request on overseas listing filing, covering absence of controlling shareholder, SOE procedures and proposed projects

Fri, 04 Sep 2026 09:57:59 GMT

NewTimeSpace News: GLB Intelligent Power Technologies Co., Ltd., in the course of its filing for overseas listing and issuance and the "full circulation" of domestic unlisted shares, has received a supplementary information request from the China Securities Regulatory Commission (CSRC), requiring supplementary explanations on seven matters, with lawyers engaged to conduct verification and issue clear legal opinions.

The matters include: (i) explaining the prices and pricing basis of each historical capital increase and equity transfer, whether there are any abnormal subscription prices or benefit transfer, whether capital contributions have been fully paid, and whether there are any circumstances of failure to perform capital contribution obligations, withdrawal of capital or defects in the method of capital contribution; explaining whether any shareholding entrustment arrangements existed in the Company's history; and issuing a concluding opinion on whether the establishment of the Company and each historical change in equity are lawful and compliant, and on the Company's legal personality and valid existence.

(ii) Explaining the pricing basis of shares subscribed by new shareholders within the 12 months prior to the submission of the overseas listing filing application, the reasons for and reasonableness of any difference from the pricing of capital increases in the same period, and the income tax payment status of the relevant transferors in the equity transfer transactions, with a clear concluding opinion on whether any benefit transfer exists. (iii) Explaining, by reference to the regulatory guidelines, the reasonableness of the Company's determination that it has no controlling shareholder or de facto controller, with specific basis provided. (iv) Explaining the progress of the state-owned shareholders' performance of state-owned share marking and other state-owned assets management procedures, and the approval or internal decision-making procedures performed in respect of the "full circulation" of shares. (v) Explaining the progress of the industrial and commercial change procedures of the employee shareholding platform, the handling of granted shares voluntarily abandoned by employees, and whether the employee shareholding plan holds any reserved shares, and whether it is lawful and compliant and free of benefit transfer.

(vi) Explaining the relevant approval, vetting or filing procedures performed for the proposed use of proceeds projects of this offering; for proposed overseas projects, explaining the performance of overseas investment approval, vetting or filing procedures. (vii) Explaining whether the shares held by shareholders proposed to participate in the "full circulation" are subject to any pledge, freezing or other defects in title.

NANJING LINGXING receives CSRC supplementary information request on overseas listing filing, covering absence of controlling shareholder, ride-hailing compliance and foreign investment access

Fri, 04 Sep 2026 09:56:00 GMT

NewTimeSpace News: Nanjing Lingxing Technology Co., Ltd., in the course of its filing for overseas listing and issuance and the "full circulation" of domestic unlisted shares, has received a supplementary information request from the China Securities Regulatory Commission (CSRC), requiring supplementary explanations on five matters, with lawyers engaged to conduct verification and issue clear legal opinions.

The matters include: (i) explaining the prices and pricing basis of each historical capital increase and equity transfer, whether there are any abnormal subscription prices or benefit transfer, whether capital contributions have been fully paid, and whether there are any circumstances of failure to perform capital contribution obligations, withdrawal of capital or defects in the method of capital contribution; explaining whether any shareholding entrustment arrangements existed in the Company's history; explaining the basis for the determination that the Company has no controlling shareholder; and issuing a concluding opinion on whether the establishment of the Company and each historical change in equity are lawful and compliant, and on the Company's legal personality and valid existence.

(iii) Explaining the subscription price and fairness of the Company's employee shareholding plan, whether the holding of incentive interests by employees after departure complies with the relevant agreement, whether any disputes or potential disputes exist, and whether any benefit transfer exists; and whether the employee shareholding platform holds any reserved or ungranted interests.

(iv) Explaining the impact on the business operations of the Company and its subsidiaries of vehicles and drivers on the ride-hailing business operation platforms that have not correspondingly obtained the "Ride-hailing Transport Certificate" and the "Ride-hailing Driver Certificate", and whether this constitutes an obstacle to this listing and issuance; whether the small and mini passenger vehicle rental business of the Company and its subsidiaries has been filed in accordance with relevant laws and regulations, the impact of any failure to complete the filing, and whether this constitutes an obstacle to this listing and issuance; and whether the business scope and actual business of the Company and its subsidiaries involve fields restricted or prohibited for foreign investment, the foreign shareholding ratio and the specific method of calculation after this listing and issuance and the "full circulation", and whether the Company will continue to comply with foreign investment access requirements.

(v) Explaining whether the shares held by shareholders proposed to participate in the "full circulation" are subject to any pledge, freezing or other defects in title.

UNIDT receives CSRC supplementary information request on overseas listing filing, covering capital contribution compliance, telecom licence and shareholder look-through

Fri, 04 Sep 2026 09:53:44 GMT

NewTimeSpace News: UniDT Co., Ltd. in the course of its filing for overseas listing and issuance and the "full circulation" of domestic unlisted shares, has received a supplementary information request from the China Securities Regulatory Commission (CSRC), requiring supplementary explanations on three matters, with lawyers engaged to conduct verification and issue clear legal opinions.

The matters include: (i) explaining the prices and pricing basis of each capital increase and equity or share transfer in the Company's history, whether there are any abnormal subscription prices or benefit transfer, whether capital contributions have been fully paid, and whether there are any circumstances of failure to perform capital contribution obligations, withdrawal of capital or defects in the method of capital contribution; and issuing a concluding opinion on whether the establishment of the Company and each historical change in equity are lawful and compliant, and whether there are any subjects prohibited by laws and regulations from holding shares.

(ii) Explaining, in light of the business scope of the Company and its subsidiaries, whether, apart from cognitive intelligence algorithm products, the Company actually engages in or plans to carry out business in other fields and whether it has obtained the necessary qualifications and licences; explaining, in accordance with the Special Administrative Measures for Foreign Investment Access (Negative List) and other relevant foreign investment management regulations, the circumstances in which the business, business scope, qualifications and licences of the Company and its subsidiaries involve fields prohibited or restricted for foreign investment; and explaining the current status of the Value-Added Telecommunication Business Operation Licence held by the Company, and whether it will continue to comply with relevant foreign investment management regulations before and after this listing and issuance and the "full circulation".

(iii) Explaining the progress of the state-owned shareholder's state-owned share marking procedures, and whether the shares held by shareholders proposed to participate in the "full circulation" are subject to any pledge, freezing or other defects in title; and conducting look-through verification of shareholders including Shanghai Wumu Enterprise Management Consulting Partnership (Limited Partnership) strictly in accordance with the requirements of Guidelines for the Application of Regulatory Rules - Overseas Issuance and Listing Type 2, and explaining whether any subject prohibited by laws and regulations from holding shares directly or indirectly holds shares in the issuer among the Company's major shareholders.

BBL HOME receives CSRC supplementary information request on overseas listing filing, covering shareholder look-through, foreign investment access and use of proceeds

Fri, 04 Sep 2026 09:51:31 GMT

NewTimeSpace News: Jiangsu BBL Home Technology Company Limited, in the course of its filing for overseas listing and issuance and the "full circulation" of domestic unlisted shares, has received a supplementary information request from the China Securities Regulatory Commission (CSRC), requiring supplementary explanations on nine matters, with lawyers engaged to conduct verification and issue clear legal opinions.

The matters include: (i) explaining whether any relationship exists among shareholders holding less than 5% of the shares, and if so, whether their shareholdings should be aggregated, with shareholders exceeding 5% subject to look-through verification; (ii) explaining the pricing basis and reasonableness of shares subscribed by new shareholders within the last 12 months, and whether the pricing is fair and free of benefit transfer; (iii) explaining the composition and positions of equity incentive participants, whether they have any relationship with the Company's other shareholders, directors, supervisors or senior management, and whether any participant is prohibited by laws and regulations from participating in the equity incentive, together with the fairness of the subscription price, agreement terms and decision-making procedures; (iv) explaining the full details of special shareholder rights arrangements, the specific circumstances of the termination provisions and the decision-making procedures performed, whether all shareholders have reached consensus, whether any disputes exist, and whether such arrangements constitute a material obstacle to this overseas listing and issuance.

The matters also include: (v) explaining, with reference to the Special Administrative Measures for Foreign Investment Access (Negative List) (2024 version), whether the business and business scope of the Company and its subsidiaries involve areas restricted or prohibited under the foreign investment access negative list, and whether the Company will continue to comply with foreign investment access policies before and after this listing and issuance and the "full circulation", as well as the specific circumstances of subsidiaries whose business scope includes real estate brokerage and property management and whether such businesses are actually carried out; (vi) listing the principal business of each domestic operating entity and its role in the overall business layout, qualifications obtained, and explaining the business model and core competitiveness in plain language; (vii) explaining the specific performance of regulatory procedures for overseas investment and foreign exchange management involving the Company's overseas subsidiaries, with a conclusion on compliance; (viii) explaining whether the shares held by shareholders proposed to participate in the "full circulation" are subject to any pledge, freezing or other defects in title; and (ix) explaining the specific project details of using the proceeds for brand promotion and the construction of a global marketing centre, the countries and regions involved, whether overseas investment is involved and whether it complies with relevant overseas investment regulations, together with the performance of relevant approvals, vetting or filing procedures, and a commitment to repatriate all proceeds to China if such procedures are still in progress.

Hong Kong AI Concept Stock Daily：Tesla Cybercab Officially Launched for Operation, Intelligent Driving Theme Generally Rose-20260904

Fri, 04 Sep 2026 09:51:03 GMT

I. Market Overview

On September 4, 2026, the three major Hong Kong indices opened higher and rebounded, with the Hang Seng Index up 1.74%, the Hang Seng TECH Index up 2.27%, and the Hang Seng China Enterprises Index up 2.02%. The Hang Seng Index's total market turnover was HK$276.9 billion, and southbound funds saw a net outflow of HK$10.021 billion. On that day, the majority of AI concept stocks rose, with the large model and intelligent driving themes mostly strengthening, while AI chips broadly weakened.

In the large model segment, MEITUAN-W (03690.HK) rose 5.28%, Baidu Group-W (09888.HK) rose 4.81%, and MINIMAX-W, ALIBABA-W, KUAISHOU-W, and TENCENT followed the gains. Z.AI (02513.HK) fell 2.98% against the trend.

In the AI chip segment, MONTAGE TECHNOLOGY (06809.HK) rose 1.24%, HUA HONG GRACE (01347.HK) fell 8.43%, and ILUVATAR COREX, SMIC, BIREN TECH, and GIGADEVICE followed the declines.

In the intelligent driving segment, influenced by Tesla Cybercab's official operation, PONY-W (02026.HK) rose 4.05%, and WERIDE-W, ROBOSENSE, and BLACK SESAME followed the gains, while HORIZONROBOT-W (09660.HK) dipped slightly by 0.34%.

In the embodied intelligence segment, XIAOMI-W (01810.HK) closed up 3.64%, and UBTECH ROBOTICS (09880.HK) rose 8.28%.

II. Market Performance of Representative AI Stocks

Stock Code	Company Name	Closing Price (HKD)	Change(%)	Sector / Concept
09880.HK	UBTECH ROBOTICS	85.650	8.28	Embodied AI
03690.HK	MEITUAN-W	81.750	5.28	LLM
09888.HK	BIDU-SW	95.900	4.81	LLM
02026.HK	PONY-W	57.750	4.05	Autonomous Driving
00800.HK	WERIDE-W	15.980	4.04	Autonomous Driving
02498.HK	ROBOSENSE	18.280	3.92	Autonomous Driving
02533.HK	BLACK SESAME	10.640	3.91	Autonomous Driving
01810.HK	XIAOMI-W	28.440	3.64	Embodied AI
01024.HK	KUAISHOU-W	33.660	2.75	LLM
09988.HK	BABA-SW	110.100	2.42	LLM
00700.HK	TENCENT	442.800	2.26	LLM
00100.HK	MINIMAX-W	361.400	1.80	LLM
06809.HK	MONTAGETECH	261.600	1.24	AI Chips
09660.HK	HORIZONROBOT-W	4.355	-0.34	Autonomous Driving
03986.HK	GIGADEVICE	464.800	-0.43	AI Chips
06082.HK	BIRENTECH	41.600	-1.14	AI Chips
00981.HK	SMIC	67.200	-1.25	AI Chips
02513.HK	Z.AI	1,075.000	-2.98	LLM
09903.HK	ILUVATAR COREX	383.600	-4.62	AI Chips
01347.HK	HUA HONG GRACE	109.700	-8.43	AI Chips

Data Source: HKEX. For reference only, not investment advice. Data as of market close on September 4, 2026.

III. AI Industry & Corporate Developments

1. OpenAI Officially Releases GPT-6 Astra and Declares "Welcome to the AGI Era"

On September 4, OpenAI officially released GPT-6 Astra, calling it "the world's most intelligent and most aligned model to date," having achieved the current state of the art in computer operation, web browsing, software engineering, cybersecurity, scientific research, and professional work. The announcement stated that GPT-6 Astra will first be opened to some enterprises participating in the cybersecurity project Daybreak, and will subsequently be rolled out to all ChatGPT subscription users "in the coming days."

2. Tmall Launches Token Recharge Center, with First Batch Connecting Alibaba Cloud, Z.AI, Kimi, and MiniMax

On September 3, Tmall officially launched the AI Space Station (Token Recharge Center), where users can directly purchase subscription products of multiple leading large models. The page shows that the recharge center aggregates subscription services from leading domestic large model vendors such as Alibaba Cloud, Z.AI, Kimi, and MiniMax. Products on sale include periodically subscribed Token Plans and Coding Plans, as well as usage-based recharge schemes, supporting two delivery methods: card keys or direct recharge.

3. NVIDIA N1X Device to Be Listed in October

News on September 3: NVIDIA (NVDA.US) announced on Thursday that the NVIDIA RTX Spark device will begin shipping in October this year. The core selling point of this computer is precisely NVIDIA's N1X chip. To be able to run AI locally, this chip supports up to 128GB of unified memory, and the Blackwell GPU it carries can provide up to petaflops of floating-point computing power per second.

4. Z.AI GLM-5.3-Flash Launches Limited-Time Free Nighttime Use

Late on September 3, Z.AI announced that from now until September 20, the GLM Coding Plan will launch the "Flash × ZCode" Changdeng campaign. From 23:00 to 9:00 the next day each night, calling the GLM-5.3-Flash included in the plan is free to use within ZCode, and the usage quota is doubled when used in other agents supported by the plan; it takes effect automatically upon entering the designated time period.

5. Tesla Cybercab Officially Launched, Domestic High-Level Autonomous Driving Advances Rapidly

On September 3 local time, Tesla announced that the cyber driverless electric vehicle Cybercab has officially entered operation in Austin, USA. Tesla stated that the model requires no steering wheel, pedals, or rearview mirror, and will undertake more travel demand with higher usage efficiency. Notably, before this launch event, Tesla had already released signals of Cybercab's further scaled operation. It is reported that Tesla's official website has quietly launched an intention registration form, targeting enterprises or individuals interested in purchasing Cybercab fleets.

IV. Profiles of Representative AI Concept Stocks

Company Name	Stock Code	Industry Position	Main Product Lines & Business Overview
MEITUAN-W	03690.HK	AI technology pioneer in local life services	Its AI-native community application “Miyu” has demonstrated operational value in physical retail and dining environments, boosting merchant efficiency. The company continuously enhances search, recommendation, and dispatch algorithms across its local commerce ecosystem using proprietary foundation models. By deploying AI Agent technologies in customer service, merchant marketing assistants, and instant delivery route planning, the company improves dual-sided operational efficiency and management precision.
XIAOMI-W	01810.HK	Full-stack AI technology giant anchored by the "Human x Car x Home" ecosystem	Its foundational model family MiMo has entered the top tier of global open-source models; MiMo-V2-Pro features over 1 trillion parameters, while MiMo-V2.5-Pro tied for 1st globally among open-source models with a score of 54 on the Artificial Analysis composite index. AI capabilities fully power the "Human x Car x Home" ecosystem, driving iterative upgrades in the CyberOne humanoid and CyberDog bionic quadrupeds. Multimodal computer vision, force-control algorithms, and automated dispatch logics are deeply integrated into dark-factory production and flexible manufacturing.
UBTECH ROBOTICS	09880.HK	The purest humanoid robot stock in Hong Kong	The company focuses on humanoid robot R&D, full‑stack motion control algorithms, and commercial deployment across industrial and logistics scenarios. Its flagship Walker S series has been integrated into assembly lines of leading new energy vehicle manufacturers for parts handling, precision assembly, and intelligent quality inspection, pioneering the transition from lab prototypes to industrial automation at scale.
PONY-W	02026.HK	Global commercialization leader in L4 autonomous mobility and logistics	The first autonomous driving company in China to secure fully driverless Robotaxi commercial operation permits across all four top-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen). Core operations span autonomous ride-hailing (Robotaxi) and freight services (Robotruck), with Robotaxi deployments across 9 countries and public operations in overseas markets including Croatia, Qatar, Singapore, and South Korea. Targeting a global fleet exceeding 3,000 vehicles across 20+ cities by 2026, the company has achieved positive unit economics per vehicle.
BIDU-SW	09888.HK	Dual-engine leader in China's AI infrastructure and autonomous driving	Financial results show AI revenue accounting for 52% of core business revenue, replacing traditional advertising as the primary growth driver. Ernie Model 5.1 is officially live, ranking 1st nationally and 4th globally on LMArena benchmarks. The Qianfan model platform aggregates mainstream foundation models for commercial API consumption, driving a 79% YoY surge in AI Cloud revenue. Apollo Go leads in fully driverless commercial operations, accumulating over 330 million operational kilometers and achieving breakeven per vehicle in select cities. Foundation model capabilities continue to penetrate AI Cloud, autonomous driving, and AI-native applications.

BINHUI BIOPHARMA files for H-share listing and "full circulation" with CSRC filing, up to 38.10 million shares to be issued

Fri, 04 Sep 2026 09:43:08 GMT

NewTimeSpace News: Wuhan Binhui Biopharmaceutical Co., Ltd. announced that its filing materials for overseas listing and issuance and the "full circulation" of domestic unlisted shares have been received by the China Securities Regulatory Commission (CSRC), and the Company has received the filing notice. Pursuant to the Securities Law of the People's Republic of China, the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies, the Business Guidelines for H-Share Companies Applying for "Full Circulation" of Domestic Unlisted Shares and other regulations, the filing matters include: the Company plans to issue no more than 38,102,600 overseas listed ordinary shares for listing on the Hong Kong Stock Exchange; and 54 shareholders of the Company plan to convert an aggregate of 150,933,379 domestic unlisted shares held by them into overseas listed shares for listing and circulation on the Hong Kong Stock Exchange.

According to the filing notice: from the date of issuance of the filing notice until the completion of this overseas issuance and listing, if any major matter occurs, the Company shall report through the CSRC filing management information system in accordance with the relevant provisions on overseas issuance and listing of domestic companies; within 15 working days after completing its overseas listing and issuance, the Company shall report the status of the listing and issuance through the filing management information system; and if the Company intends to continue and has not completed the overseas listing and issuance and share conversion within 12 months from the date of the filing notice, it shall update the filing materials.

The filing notice only confirms the filing information of the Company's overseas listing and issuance and "full circulation", and does not constitute a substantive judgement by the CSRC on the investment value of the Company's securities or investors' returns, nor a guarantee by the CSRC of the authenticity, accuracy or completeness of the Company's filing materials.

AUTOLINK files for H-share listing and "full circulation" with CSRC filing, up to 68.26 million shares to be issued

Fri, 04 Sep 2026 09:36:17 GMT

NewTimeSpace News: Wuxi Autolink Intelligence Tech Co., Ltd. announced that its filing materials for overseas listing and issuance and the "full circulation" of domestic unlisted shares have been received by the China Securities Regulatory Commission (CSRC), and the Company has received the filing notice. Pursuant to the Securities Law of the People's Republic of China, the Trial Administrative Measures for Overseas Securities Offering and Listing by Domestic Companies, the Business Guidelines for H-Share Companies Applying for "Full Circulation" of Domestic Unlisted Shares and other regulations, the filing matters include: the Company plans to issue no more than 68,263,500 overseas listed ordinary shares for listing on the Hong Kong Stock Exchange; and 39 shareholders of the Company plan to convert an aggregate of 336,371,100 domestic unlisted shares held by them into overseas listed shares for listing and circulation on the Hong Kong Stock Exchange.

KANGDA ENV (06136.HK): Completes Issuance of USD 50 Million 8.0% Senior Notes Due 2029

Fri, 04 Sep 2026 09:18:11 GMT

NewTimeSpace News: On 4 September 2026, Kangda International Environmental Company Limited (stock code: 06136) announced that its senior notes with an aggregate principal amount of USD 50 million, bearing interest at 8.0% per annum and due in 2029, were fully issued on 4 September 2026.

According to the announcement, this is the Company's first notes issuance after obtaining international credit ratings in May 2026, with SMBC Nikko Securities (Hong Kong) Limited acting as the sole placing agent. The notes bear interest at 8.0% per annum, payable semi-annually, with a tenor of three years; the net proceeds will be used to repay certain debts and fund working capital.

NewTimeSpace | Hong Kong Market Close: The three major indices opened higher and rebounded, with the Hang Seng Index closing up 1.74%, and themes such as media, industrial trade & commerce, and conglomerates led the gains

Fri, 04 Sep 2026 09:15:54 GMT

NewTimeSpace (newtimespace.com) reported, September 4, 2026—the three major Hong Kong indices opened higher and rebounded, with the Hang Seng Index up 1.74%, the Hang Seng TECH Index up 2.27%, and the Hang Seng China Enterprises Index up 2.02%. The Hang Seng Index's total market turnover was HK$276.9 billion, notably expanding from the previous trading day. Southbound funds saw a net outflow of HK$10.021 billion.

On the market, by sector.Themes such as media, industrial trade & commerce, and conglomerates and food & beverage led the gains. Themes such as semiconductors, medical devices and services, and paper and packaging led the declines.

Among them, of the Hang Seng Index constituents, 80 rose and 11 fell.On the upside, LONGFOR GROUP gained 8.40%, LENOVO GROUP gained 6.09%, and MEITUAN-W gained 5.28%. On the downside, WUXI BIO fell 3.00%, OOIL fell 2.48%, and SMIC fell 1.25%.

Among the Hang Seng TECH Index constituents, 24 rose and 6 fell.On the upside, TONGCHENGTRAVEL gained 6.84%, SENSETIME-W gained 5.86%, and Baidu Group-W gained 4.81%. On the downside, HUA HONG GRACE fell 8.43%, Z.AI fell 2.98%, and NIO-SW fell 0.67%.

Among the HK Stock Connect constituents,PHANCY surged 14.66%; SUNAC surged 14.29%, and MARKETINGFORCE surged 13.52%. GENSCRIPT BIO fell 13.33%, CF PHARMTECH fell 6.78%, and NEXTEER fell 6.45%.

CINDA INTL HLDG pointed outthat yesterday's Hong Kong market turnover was weak, with the TECH Index falling to a low since July: the Hang Seng Index opened higher yesterday but eventually reversed to close lower, again falling near the early-August low of 25,089 points. The TECH Index performed even weaker, falling more than 1%, hitting a new low since July. Yesterday's Hong Kong market trading was relatively quiet, with total market turnover below HK$200 billion, the first time since May 5, though at that time it was the May Day Golden Week, and the HK Stock Connect suspension caused the lower turnover amount.

Hong Kong stocks should see a rebound this morning, but the momentum may be limited:the latest probability of a US rate hike in September has decreased, overseas long-bond yields have retreated slightly, and the Hang Seng Index's overnight futures traded at a premium; a rebound is expected this morning, but the momentum may be limited. In the short term, the upward resistance reference is the 250-day moving average at around 25,763 points, while the support level is the bottom of the mid-to-late-month consolidation range at around 24,800 points. (Source: CINDA INTL HLDG, September 4, 2026, "Hong Kong Morning Express")

LONGSYS (09976.HK): Offer price fixed at HKD 236.00 per share, listing on 8 September

Fri, 04 Sep 2026 08:51:32 GMT

NewTimeSpace News: On 4 September 2026, Shenzhen Longsys Electronics Co., Ltd. (stock code: 09976) announced the offer price. On 4 September 2026, the offer price was fixed at HKD 236.00 per H share (excluding 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00565% Stock Exchange trading fee and 0.00015% Accounting and Financial Reporting Council transaction levy).

The Company expects to announce on 7 September 2026 (Monday) the details of the level of interest in the international offering, the application levels under the Hong Kong public offering, the basis of allotment of the Hong Kong offer shares and the allotment results of the Hong Kong public offering. Assuming the global offering becomes unconditional on or before 8:00 a.m. (Hong Kong time) on 8 September 2026 (Tuesday), the H shares are expected to commence trading on the Main Board of the Stock Exchange at 9:00 a.m. (Hong Kong time) on 8 September 2026, in board lots of 50 shares.

HK shares ETFs Daily Report : Fintech Surged Nearly 8%; Blockchain and Digital Technology Stocks Exploded Across the Board While China Little Giant ETFs Plunged Against the Trend - 20260904

Fri, 04 Sep 2026 08:27:27 GMT

NewTimeSpace News: On September 4, 2026, the HK shares ETFs market showed surging fintech, blockchain, Korea and Vietnam themes, while China Little Giant, STAR 50, China semiconductor and 5G ETFs came under pressure and pulled back again, with sector divergence extremely pronounced.

Fintech and blockchain themes were extremely strong during the session. Global X Innovative Finance ETF (3185.HK) rose 7.81%, the largest gain; SAMSUNG Blockchain Technologies ETF (3171.HK) advanced 5.41%; Pando Blockchain ETF (3112.HK) gained 4.48%; E Fund (HK) Wind Digital Technology Index ETF (3434.HK) rose 4.25%; E Fund (HK) CSI Liquor Index ETF (3189.HK) advanced 3.66%; Doo Wealth Selected Web3 ETF (3426.HK) rose 3.02%; Phillip HK Newly Listed Equities Index ETF (2835.HK) gained 2.95%; CSOP KOSPI 200 ETF (3121.HK) rose 2.93%; CSOP FTSE HK-Korea Tech+ Index ETF (3431.HK) advanced 2.88%; and CSOP FTSE Vietnam 30 ETF (3004.HK) rose 2.86%. Overall, fintech, blockchain, digital technology and Korea/Vietnam themes formed a strong sector linkage, with all of the top-10 gainers up more than 2.8%.

HK shares ETFs Top 10 Gainers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	3185.HK	Global X Innovative Finance ETF	7.81	--	Mirae Asset Global Investments (Hong Kong)
2	3171.HK	SAMSUNG Blockchain Technologies ETF	5.41	--	Samsung Asset Management (Hong Kong) Limited
3	3112.HK	Pando Blockchain ETF	4.48	--	Pando Limited
4	3434.HK	E Fund (HK) Wind Digital Technology Index ETF	4.25	Wind Digital Technology Net Total Return Index (HKD)	E Fund Asset Management (Hong Kong) Limited
5	3189.HK	E Fund (HK) CSI Liquor Index ETF	3.66	CSI Liquor Index	E Fund Asset Management (Hong Kong) Limited
6	3426.HK	Doo Wealth Selected Web3 ETF	3.02	--	Doo Financial HK Limited
7	2835.HK	Phillip HK Newly Listed Equities Index ETF	2.95	Solactive Hong Kong Newly Listed Equities Index (Net Total Return)	Phillip Capital Management (Hong Kong) Limited
8	3121.HK	CSOP KOSPI 200 ETF	2.93	--	CSOP Asset Management Limited
9	3431.HK	CSOP FTSE HK-Korea Tech+ Index ETF	2.88	--	CSOP Asset Management Limited
10	3004.HK	CSOP FTSE Vietnam 30 ETF	2.86	FTSE Vietnam 30 Price Index	CSOP Asset Management Limited
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 4, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

On the downside, China Little Giant and STAR 50 ETFs led the declines. Global X China Little Giant ETF (2815.HK) fell 3.08%, the biggest drop; Premia China STAR50 ETF (3151.HK) declined 1.83%; Bosera STAR 50 Index ETF (2832.HK) fell 1.62%; CSOP STAR 50 Index ETF (3109.HK) declined 1.46%; Global X China Semiconductor ETF (3191.HK) fell 1.39%; CSOP YINHUA CSI 5G Communications Theme ETF (3193.HK) declined 1.16%; Global X China Robotics and AI ETF (2807.HK) fell 0.72%; CSOP CSI 500 ETF (3005.HK) declined 0.62%; Global X China Core TECH ETF (3448.HK) fell 0.57%; and iShares Core MSCI Taiwan Index ETF (3074.HK) declined 0.56%. China Little Giant, STAR 50, China semiconductor and 5G ETFs came under pressure during the session, but aside from the Little Giant complex, none of the declines exceeded 1.9%.

HK shares ETFs Top 10 Decliners
No.	Code	Name	Change (%)	Tracking Index	Manager
1	2815.HK	Global X China Little Giant ETF	-3.08	Solactive China Little Giant Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
2	3151.HK	Premia China STAR50 ETF	-1.83	SSE STAR 50 Index	Premia Partners
3	2832.HK	Bosera STAR 50 Index ETF	-1.62	SSE STAR 50 Index	Bosera Asset Management (International)
4	3109.HK	CSOP STAR 50 Index ETF	-1.46	SSE STAR 50 Index	CSOP Asset Management Limited
5	3191.HK	Global X China Semiconductor ETF	-1.39	FactSet China Semiconductor Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
6	3193.HK	CSOP YINHUA CSI 5G Communications Theme ETF	-1.16	CSI 5G Communication Index	CSOP Asset Management Limited
7	2807.HK	Global X China Robotics and AI ETF	-0.72	FactSet China Robotics and Artificial Intelligence Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
8	3005.HK	CSOP CSI 500 ETF	-0.62	CSI 500 Index	CSOP Asset Management Limited
9	3448.HK	Global X China Core TECH ETF	-0.57	Mirae Asset China Technology Top 30 Index (Net Return, HKD)	Mirae Asset Global Investments (Hong Kong)
10	3074.HK	iShares Core MSCI Taiwan Index ETF	-0.56	MSCI Taiwan Index	BlackRock Asset Management North Asia Limited
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 4, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

NewTimeSpace Research data showed that on September 4, 2026, the HK shares ETFs market featured a rotation in which fintech and blockchain themes exploded while China technology themes came under pressure. Fintech, blockchain, digital technology and Korea/Vietnam themes drew concentrated surges and led the gains, whereas China Little Giant, STAR 50, China semiconductor and 5G ETFs pulled back across the board. Market hotspots rotated swiftly from the previous session's gold miner and Taiwan/Japan themes to fintech and blockchain, with the fintech sector becoming the day's dominant line and China technology themes extending their adjustment; sector rotation continued to be fast-paced.

EXCELLAND ROBOTICS (03231.HK): Public offering ends today with margin financing of HKD 4.214 billion, actual oversubscription of over 95 times

Fri, 04 Sep 2026 08:26:26 GMT

NewTimeSpace News: The public offering of Excelland Robotics (Wuxi) Co. Ltd. (stock code: 03231) closed today (4 September 2026), with margin financing totalling HKD 4.214 billion as of 11:51 a.m., against a public offering size of HKD 43.99 million, representing an actual margin financing multiple of 95.79 times.

In respect of the offering mechanism, the Company is listed under Chapter 18C of the Main Board Listing Rules (Specialist Technology Companies mechanism); the offering period ran from 31 August to 4 September 2026, and the listing date is 9 September 2026.

In respect of the offering structure, the Company made a global offering of 45,000,000 shares (representing approximately 10.81% of the enlarged total share capital of 416 million shares), comprising 2,250,000 shares under the Hong Kong public offering (5.00%) and 42,750,000 shares under the international placing (95.00%); the public offering comprised 22,500 board lots of 200 shares each, with an application fee of HKD 3,949.44, and an offer price range of HKD 14.450-19.550 per share.

In respect of the use of proceeds: approximately 48.5% (approximately HKD 332.5 million) will be used to further enhance R&D capabilities to expand the coverage of diverse scenarios across domestic and overseas markets and continue to strengthen technology; approximately 30.0% (approximately HKD 205.7 million) will be used for business expansion and strategic acquisitions; approximately 7.0% (approximately HKD 48.0 million) will be used to enhance sales and marketing capabilities; approximately 4.5% (approximately HKD 30.9 million) will be used for partial repayment of bank loans; and approximately 10% (approximately HKD 68.6 million) will be used for working capital and other general corporate purposes.

MEDCAPTAIN (02041.HK): Grey-market opens18.5% lower at HKD 12.59

Fri, 04 Sep 2026 08:20:39 GMT

NewTimeSpace News: Shenzhen Medcaptain Bio-Medical Technology Co., Ltd. (stock code: 02041) conducted grey-market trading on 4 September 2026, opening18.5% lower at HKD 12.59. The Company expects its H shares to begin trading on the Main Board of the Hong Kong Stock Exchange at 9:00 a.m. on Monday, 7 September 2026.

Founded in 2011 in Shenzhen, Guangdong Province, the Company is a global medical device provider with three business segments: life support, minimally invasive intervention, and in-vitro diagnostics, meeting the clinical needs of clinical departments, wards and clinics within medical institutions, as well as community health centres, testing institutions and home care scenarios. As of 31 March 2026, the Company's product portfolio included over 60 life support products, 110 minimally invasive intervention products and 150 in-vitro diagnostic products. During the track record period, the Company strategically established five R&D centres and six production centres in China and the United Kingdom.

Shanghai-Shenzhen Stock Connect ETFs Daily Report: Animal Husbandry ETFs Surged Over 4.5%; Media and Consumer Staples Rallied Broadly While Semiconductor Equipment Came Under Heavy Pressure Again - 20260904

Fri, 04 Sep 2026 07:55:31 GMT

NewTimeSpace News: On September 4, 2026, the Shanghai-Shenzhen Stock Connect ETFs market featured broad gains in defensive consumer sectors such as animal husbandry, media, agriculture and consumer staples, while technology themes including semiconductor equipment, STAR semiconductors and machine tools pulled back collectively again, with animal husbandry becoming the day's dominant line.

Animal husbandry and media/consumer staples themes were extremely strong during the session. Guotai CSI Animal Husbandry ETF (159865.SZ) rose 4.60%, the largest gain; China Merchants CSI Animal Husbandry ETF (516670.SH) advanced 4.58%; and Penghua CSI Animal Husbandry ETF (159867.SZ) gained 4.32%. Agriculture rallied in tandem: Tianhong CSI Agriculture Theme ETF (512620.SH) rose 3.85%, and Fullgoal CSI Agriculture Theme ETF (159825.SZ) gained 3.48%.

Media and consumer staples also delivered solid performance: Penghua CSI Media Index ETF (159805.SZ) rose 3.55%; GF CSI Media Index ETF (512980.SH) gained 3.51%; China Universal CSI Consumer Staples ETF (159928.SZ) rose 3.31%; Penghua CSI Alcoholic Drink Index ETF (512690.SH) gained 3.09%; and Harvest CSI Consumer Staples ETF (512600.SH) rose 2.62%. Overall, animal husbandry, media, agriculture and consumer staples formed a strong defensive consumer-sector linkage, with all of the top-10 gainers up more than 2.6%.

Shanghai-Shenzhen Stock Connect ETF Top 10 Gainers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	159865.SZ	Guotai CSI Animal Husbandry ETF	4.60	CSI Animal Husbandry Index	Guotai Asset Management
2	516670.SH	China Merchants CSI Animal Husbandry ETF	4.58	CSI Animal Husbandry Index	China Merchants Fund Management
3	159867.SZ	Penghua CSI Animal Husbandry ETF	4.32	CSI Animal Husbandry Index	Penghua Fund Management
4	512620.SH	Tianhong CSI Agriculture Theme ETF	3.85	CSI Agriculture Theme Index	Tianhong Asset Management
5	159805.SZ	Penghua CSI Media Index ETF	3.55	CSI Media Index	Penghua Fund Management
6	512980.SH	GF CSI Media Index ETF	3.51	CSI Media Index	GF Fund Management
7	159825.SZ	Fullgoal CSI Agriculture Theme ETF	3.48	CSI Agriculture Theme Index	Fullgoal Fund Management
8	159928.SZ	China Universal CSI Consumer Staples ETF	3.31	CSI 800 Consumer Staples Index	China Universal Asset Management
9	512690.SH	Penghua CSI Alcoholic Drink Index ETF	3.09	CSI Alcoholic Drink Index	Penghua Fund Management
10	512600.SH	Harvest CSI Consumer Staples ETF	2.62	CSI 800 Consumer Staples Index	Harvest Fund Management
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onSeptember 4, 2026

On the downside, semiconductor equipment and STAR semiconductor ETFs led the declines, with several related ETFs down more than 3%. GF CSI Semiconductor Material Equipment Theme ETF (560780.SH) fell 3.70%, the biggest drop; ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (588170.SH) declined 3.53%; Guotai CSI Machine Tool ETF (159667.SZ) fell 3.38%; Penghua China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (589020.SH) declined 3.34%; Huatai-PB China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (588710.SH) fell 3.32%; ChinaAMC CSI Semiconductor Material Equipment Theme ETF (562590.SH) declined 3.24%; E Fund SSE Science And Technology Innovation Board Growth ETF (588020.SH) fell 3.21%; Wanjia CSI Semiconductor Material Equipment Theme ETF (159327.SZ) declined 3.13%; E Fund CSI Semiconductor Material Equipment Theme ETF (159558.SZ) fell 3.10%; and Guotai CSI Semiconductor Material Equipment Theme ETF (159516.SZ) declined 3.10%. Semiconductor equipment, STAR semiconductor, machine tool and STAR growth ETFs met evident selling pressure during the session, with all of the top-10 decliners down more than 3.1%.

Shanghai-Shenzhen Stock Connect ETF Top 10 Losers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	560780.SH	GF CSI Semiconductor Material Equipment Theme ETF	-3.70	CSI Semiconductor Material Equipment Theme Index	GF Fund Management
2	588170.SH	ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-3.53	SSE STAR Semiconductor Material Equipment Theme Index	China Asset Management
3	159667.SZ	Guotai CSI Machine Tool ETF	-3.38	CSI Machine Tool Index	Guotai Asset Management
4	589020.SH	Penghua China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-3.34	SSE STAR Semiconductor Material Equipment Theme Index	Penghua Fund Management
5	588710.SH	Huatai-PB China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-3.32	SSE STAR Semiconductor Material Equipment Theme Index	Huatai-PineBridge Fund Management
6	562590.SH	ChinaAMC CSI Semiconductor Material Equipment Theme ETF	-3.24	CSI Semiconductor Material Equipment Theme Index	China Asset Management
7	588020.SH	E Fund SSE Science And Technology Innovation Board Growth ETF	-3.21	SSE STAR Growth Index	E Fund Management
8	159327.SZ	Wanjia CSI Semiconductor Material Equipment Theme ETF	-3.13	CSI Semiconductor Material Equipment Theme Index	Wanjia Asset Management
9	159558.SZ	E Fund CSI Semiconductor Material Equipment Theme ETF	-3.10	CSI Semiconductor Material Equipment Theme Index	E Fund Management
10	159516.SZ	Guotai CSI Semiconductor Material Equipment Theme ETF	-3.10	CSI Semiconductor Material Equipment Theme Index	Guotai Asset Management
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onSeptember 4, 2026

NewTimeSpace Research data showed that on September 4, 2026, the Shanghai-Shenzhen Stock Connect ETFs market featured a rotation in which animal husbandry and consumer staples strengthened broadly while semiconductor equipment ETFs came under pressure again. Defensive consumer themes such as animal husbandry, media, agriculture and consumer staples drew concentrated buying and led the gains, whereas technology themes including semiconductor equipment, STAR semiconductors, machine tools and STAR growth pulled back across the board. Market hotspots rotated swiftly from the previous session's gold stocks and innovative drugs to animal husbandry and the media/consumer staples complex, with animal husbandry becoming the day's dominant line and consumer staples also delivering solid performance, while technology sectors extended their adjustment.

Autonomous Driving Concept Stocks Watch | XPENG-W (09868.HK) Trades Firm; Second‑Generation VLA Physical‑World Large Model Sees First Major Iteration

Fri, 04 Sep 2026 07:32:13 GMT

NewTimeSpace News: On September 4, 2026, XPENG-W (09868.HK) traded firmly in the afternoon session. As of 15:15, the stock traded at HK$43.54, up 1.73%.

According to China Business Journal, Xpeng recently held the“TIME”Physical AI Experience Day in Guangzhou. Its second‑generation VLA physical‑world large‑scale model has undergone its first major iteration. The brand‑new XOS 6.3.0 system will make its global debut on the Xpeng G9L.

Jiemian News reported that starting from September 1, multiple Chinese new‑energy vehicle startups released their August 2026 delivery figures. Leapmotor delivered 103,129 vehicles globally, representing an 80.7% year‑on‑year increase; Xpeng Group delivered 39,107 vehicles, up 4% year‑on‑year; Li Auto delivered 37,679 vehicles, a 32.1% year‑on‑year rise; NIO delivered 35,836 vehicles, growing 14.5% year‑on‑year.

XPENG-W (09868.HK) Focuses on the full-stack in-house R&D and large-scale deployment of end-to-end autonomous driving foundational models for mass-produced vehicles. Its proprietary XNGP (Advanced Driver Assistance System) has completely decoupled from high-definition maps, demonstrating exceptional generalization capabilities in complex urban NOA (Navigation Guided Pilot) scenarios. The activation rate of advanced ADAS and the mileage penetration rate among users of newly delivered models remain at the industry forefront, providing a highly deterministic benchmark for vehicle-side AI application delivery.

AI Chip Concept Stocks Watch | Hua Hong Grace (01347.HK) Slumped Sharply, Recently Announced Construction of a Wafer Foundry Line with Planned Monthly Capacity of 55,000 Wafers

Fri, 04 Sep 2026 05:52:38 GMT

NewTimeSpace (newtimespace.com) News, September 4, 2026—The chip theme continued to come under pressure, with Hua Hong Grace (01347.HK) slumping sharply. As of 13:40, the stock was quoted at HK$109.100, down 8.93%.

On the news front, Hua Hong Grace recently announced that the company and its wholly-owned subsidiary, Shanghai Hua Hong Grace Semiconductor Manufacturing Co., Ltd., intend to jointly increase the capital of Wuxi Hua Hong Grace Phase III Semiconductor Co., Ltd. together with three other companies including Wuxi Xihong Guoxin Phase II Investment Co., Ltd., to build a 12-inch specialty-process wafer foundry line with a planned monthly capacity of approximately 55,000 wafers.

Guosheng Securities pointed out that the capabilities of domestic chips have continued to improve, narrowing the generation gap with overseas chips. The adoption of domestic chips by internet and intelligent computing centers has accelerated, and domestic computing power demand is shifting faster toward local manufacturers. The expansion of application scenarios and the accumulation of experience have effectively driven the iterative upgrading of chip capabilities, and a positive R&D feedback loop is gradually taking shape.

HUA HONG GRACE(01347.HK)Specializes in specialty process wafer foundry, offering customized manufacturing of power discretes, embedded non-volatile memory, analog and power management ICs. Its 8-inch and 12-inch production lines serve automotive, industrial control and data center power management applications. The company holds multiple automotive-grade quality certifications and provides mass production foundry services to various domestic and international automotive clients. Its overall capacity utilization has remained high over an extended period.

Humanoid Robot Concept Stocks Watch | Midea Group (00300.HK) up 0.50%, Shenzhen unveils robot high-quality development plan

Fri, 04 Sep 2026 05:31:41 GMT

NewTimeSpace (newtimespace.com) News, on September 4, 2026, the robotics theme weakened amid volatility, while Midea Group (00300.HK) strengthened against the trend. As of 13:26, the company's quote was HK$101.000, up 0.50%.

On the news front, Shenzhen recently issued the "Shenzhen Work Plan for Promoting High-Quality Development of the Intelligent Robotics Industry (2026–2028)." The plan proposes that by 2028, Shenzhen will be built into the world's most influential smart robotics industry highland, creating the country's most vibrant smart robotics innovation enterprise cluster, a globally leading smart robotics software-and-hardware supporting cluster, and an international robot-friendly demonstration city center, as well as a Guangdong-Hong Kong-Macao Greater Bay Area robotics open-source ecosystem center, thereby forming a new industrial pattern featuring the coordinated development of the "two zones and two centers."

Western Securities believes that 2026 is expected to be the first year of scaled mass production for the humanoid robotics industry. At the policy level, embodied intelligence is explicitly promoted as a new economic growth driver; at the technology level, breakthroughs in AI and large models provide the "smart brain"; and at the demand level, the intensifying aging population gives rise to space for labor substitution.

MIDEA GROUP (00300.HK) Comprehensively positions itself within the industrial-grade embodied AI and core automation equipment supply chain through its wholly-owned subsidiary KUKA, one of the "Big Four" global industrial robot giants. The company focuses on the R&D and delivery of high-precision articulated robotic arms, heavy-duty logistics AGVs, and industrial automation software systems. Its intelligent manufacturing solutions are widely deployed across core heavy-asset production lines globally, including automotive manufacturing and electronic semiconductors. Backed by industry-leading delivery metrics for industrial-grade robots, it serves as the foundational infrastructure anchor for the sector.

HONY MEDIA (00419.HK): Signs cooperation agreement with A-Living Smart Property Services on property robot operation platform

Fri, 04 Sep 2026 05:07:55 GMT

NewTimeSpace News: On 4 September 2026, Hony Media Group (stock code: 00419) voluntarily announced that Ainuobo (Chengdu) Technology Co., Ltd., an indirect subsidiary of the Group, has signed the "Cooperation Agreement on Joint Construction and Operation of a Property Robot Operation Platform" with A-Living Smart Property Services Co., Ltd. ("A-Living Smart Property Services"), with a cooperation term of five years. The parties will use the Group's AIROBO operating system as the technology foundation to jointly construct and operate a property service robot operation management platform, achieving unified access and unified operation management of robots of multiple brands and categories, and promoting the scaled application of robots in community and property scenarios. The cooperation will help the Group verify and accumulate robot operation capabilities in real property scenarios and gradually develop a replicable operation model.

A-Living Smart Property Services is a wholly-owned subsidiary of A-Living Smart City Services Co., Ltd. ("A-Living Services"), a company listed on the Stock Exchange (stock code: 3319). A-Living Services manages properties with an aggregate GFA of over 500 million square metres, over 3,800 projects under management, and has entered nearly 200 cities across China; in 2025, A-Living Services recorded revenue of over RMB 12.8 billion.

To the best of the directors' knowledge, information and belief after making all reasonable enquiries, A-Living Smart Property Services and its ultimate beneficial owners are independent third parties of the Company and its connected persons. The Company noted that the specific progress of the cooperation is subject to the project documents to be signed by the parties subsequently and the actual progress, and there remains certain uncertainty.

China Merchants CSI Animal Husbandry ETF (516670) latest price at RMB 0.63, CSI Animal Husbandry Industry Index (930707) up 2.48%

Fri, 04 Sep 2026 02:41:08 GMT

NewTimeSpace (newtimespace.com) News, as of 10:31 on September 4, 2026, the CSI Animal Husbandry Industry Index (930707) rose strongly by 2.48%, and the China Merchants CSI Animal Husbandry ETF (516670) latest price was RMB 0.63.

In terms of liquidity, the China Merchants CSI Animal Husbandry ETF recorded an intraday turnover rate of 1.17% and turnover of RMB 24.3993 million. Over a longer horizon, as of September 3, the ETF's average daily turnover over the past week was RMB 45.8661 million.

In terms of scale, the China Merchants CSI Animal Husbandry ETF's assets under management grew by RMB 71.3747 million over the past month, achieving significant growth. (Source: Wind)

In terms of shares outstanding, the China Merchants CSI Animal Husbandry ETF's shares increased by 27 million shares over the past month, achieving significant growth. (Source: Wind)

In terms of capital inflows, the China Merchants CSI Animal Husbandry ETF's latest net capital OUTFLOW was RMB 0.6134 million. Over a longer horizon, among the past 23 trading days, there were 13 days of net inflows, aggregating to net inflows of RMB 15.9928 million. (Source: Wind)

Data shows that leveraged funds are continuing to build positions. The China Merchants CSI Animal Husbandry ETF's margin net buy amount on the previous trading day reached RMB 1.13 million, and its latest margin balance reached RMB 28.5937 million. (Source: Wind)

As of September 3, the China Merchants CSI Animal Husbandry ETF's net value rose 9.20% over the past 2 years, ranking first among comparable funds. In terms of return capability, as of September 3, 2026, since its inception, the ETF's highest single-month return was 17.82%, its longest streak of monthly gains was 4 months, its longest cumulative gain streak was 18.92%, and the average return rate in up-months was 4.71%. As of September 3, 2026, the ETF's annualized excess return over its benchmark over the past 3 months was 4.47%, ranking top 2/4 among comparable funds.

In terms of drawdown, as of September 3, 2026, the China Merchants CSI Animal Husbandry ETF's drawdown relative to its benchmark year-to-date was 0.21%, with relatively low drawdown risk among comparable funds.

In terms of fees, the China Merchants CSI Animal Husbandry ETF has a management fee rate of 0.20% and a custody fee rate of 0.10%.

In terms of tracking precision, as of September 3, 2026, the China Merchants CSI Animal Husbandry ETF's tracking error over the past month was 0.020%.

It is worth noting that the CSI Animal Husbandry Industry Index tracked by the fund is at a historical valuation low, with its latest price-to-book ratio (PB) at 2.45x, lower than over 83.8% of the time over the past 5 years, indicating outstanding valuation cost-performance.

The China Merchants CSI Animal Husbandry ETF (516670) closely tracks the CSI Animal Husbandry Industry Index. The CSI Animal Husbandry Industry Index selects securities of listed companies involved in businesses such as livestock and poultry feed, livestock and poultry pharmaceuticals, and livestock and poultry farming as index constituents, so as to reflect the overall performance of relevant listed companies in animal husbandry.

GF CSI Media Index ETF (512980) latest price at RMB 0.86, with shares outstanding up 294 million shares over the past week

Fri, 04 Sep 2026 02:08:26 GMT

NewTimeSpace (newtimespace.com) News, as of 09:57 on September 4, 2026, the CSI Media Index (399971) rose strongly by 3.96%, and the GF CSI Media Index ETF (512980) latest price was RMB 0.86.

In terms of liquidity, the GF CSI Media Index ETF recorded an intraday turnover rate of 4.19% and turnover of RMB 181 million. Over a longer horizon, as of September 3, the ETF's average daily turnover over the past week was RMB 405 million.

In terms of scale, the GF CSI Media Index ETF's assets under management grew by RMB 319 million over the past week, achieving significant growth. (Source: Wind)

In terms of shares outstanding, the GF CSI Media Index ETF's shares increased by 294 million shares over the past week, achieving significant growth. (Source: Wind)

In terms of capital inflows, the GF CSI Media Index ETF's latest net capital inflow was RMB 126 million. Over a longer horizon, among the past 5 trading days, there were 3 days of net inflows, aggregating to net inflows of RMB 283 million, with an average daily net inflow of RMB 56.5033 million. (Source: Wind)

Data shows that leveraged funds are continuing to build positions. The GF CSI Media Index ETF's latest margin buy turnover reached RMB 14.7419 million, and its latest margin balance reached RMB 115 million. (Source: Wind)

As of September 3, the GF CSI Media Index ETF's net value rose 42.87% over the past 2 years. In terms of return capability, as of September 3, 2026, since its inception, the ETF's highest single-month return was 26.55%, its longest streak of monthly gains was 6 months, its longest cumulative gain streak was 87.46%, the average return rate in up-months was 6.59%, and its annual profitability percentage was 62.50%. As of September 3, 2026, since inception, the ETF's annualized excess return over its benchmark was 1.66%.

In terms of drawdown, as of September 3, 2026, the GF CSI Media Index ETF's drawdown relative to its benchmark over the past half-year was 0.46%, the smallest drawdown among comparable funds.

In terms of fees, the GF CSI Media Index ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%, the lowest fee rate among comparable funds.

In terms of tracking precision, as of September 3, 2026, the GF CSI Media Index ETF's tracking error over the past month was 0.016%, the highest tracking precision among comparable funds.

From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI Media Index tracked by the GF CSI Media Index ETF (512980) is only 31.46x, standing at the 12.65th percentile over the past year, i.e., its valuation is lower than that of over 87.35% of the time over the past year, remaining at a historical low.

The GF CSI Media Index ETF (512980) closely tracks the CSI Media Index. The CSI Media Index selects 50 listed company securities with relatively large total market capitalization from industries such as marketing and advertising, cultural entertainment, and digital media as index constituents, so as to reflect the overall performance of representative listed company securities in the media sector.

GENSCRIPT BIO (01548.HK): Proposes spin-off and separate listing of Probio Technology on the Main Board

Fri, 04 Sep 2026 00:41:40 GMT

NewTimeSpace News: On 4 September 2026, Genscript Biotech Corporation (stock code: 01548) announced, pursuant to Rule 13.09 of the Listing Rules, the inside information provisions and Practice Note 15, its proposal to spin off Probio Technology Limited ("Probio"), an indirect non-wholly-owned subsidiary of the Company responsible for the Group's biologics and advanced therapies contract research, development and manufacturing organisation (CDMO) services, and to list its shares separately on the Main Board of the Stock Exchange.

In respect of the proposed spin-off, the Company has submitted an application to the Stock Exchange under Practice Note 15, and the Listing Committee confirmed on 14 August 2026 that the Company may proceed with the proposed spin-off. Details of the proposed spin-off are yet to be finalised; upon completion of the proposed spin-off, the Company will continue to hold a controlling interest in Probio, which will remain a subsidiary of the Company with its financial results continuing to be consolidated into the Group's financial statements.

Under Practice Note 15, if the proposed spin-off proceeds, the Company will give due consideration to the interests of existing shareholders and, through a preferential application arrangement, provide shareholders with a guaranteed allocation of shares to be issued by Probio (the terms of which are yet to be finalised, with all eligible shareholders of the Company to be treated equally in any event). If the proposed spin-off is implemented, it will constitute a deemed disposal of the Company's interest in a subsidiary under Rule 14.29 of the Listing Rules. As the proposed spin-off is subject to, among other things, the final approval of the Listing Committee, market conditions and other considerations, it may or may not proceed.

SALUBRIS files for listing on HKEX: the second largest in China by 2025 hospital sales of cardiovascular drugs, with innovative drugs accounting for over half of revenue

Fri, 04 Sep 2026 00:29:52 GMT

NewTimeSpace News: On 3 September 2026, Shenzhen Salubris Pharmaceuticals Co., Ltd. filed its listing application with the Hong Kong Stock Exchange, with Goldman Sachs, Citigroup and CITIC Securities acting as joint sponsors. The Company is a leading pharmaceutical company in China focusing on the treatment of cardiovascular-kidney-metabolic (CKM) syndrome diseases, principally engaged in the research, development, production and sales of pharmaceutical products and medical devices. According to Frost & Sullivan, by in-hospital sales revenue of cardiovascular drugs in China, the Company ranked second in 2025 with a market share of 11.3%; as of the latest practicable date, by the number of marketed NMEs targeting CKM syndrome and pipeline candidates at the IND stage or later, the Company ranked second among domestic enterprises.

CKM syndrome is a systemic disease characterised by pathophysiological interactions among metabolic risk factors, chronic kidney disease (CKD) and the cardiovascular system, with the prevalence of CKM syndrome among adults globally reaching 88.9% in 2025. Given the chronic nature of CKM syndrome, patients require long-term or even lifelong treatment, and mature innovative originator products typically deliver higher patient retention rates and longer commercial lifecycles. Revenue generated from the Company's sales of CKM syndrome drugs amounted to RMB 1,897.1 million, RMB 2,345.5 million and RMB 2,899.1 million in 2023, 2024 and 2025 respectively, and RMB 1,422.0 million and RMB 1,722.9 million for the six months ended 30 June 2025 and 2026 respectively, representing 61.9%, 65.1%, 75.6%, 75.1% and 77.8% of total drug sales revenue in the respective periods.

The product portfolio is strategically centred on innovative drugs, further diversified into generics, biosimilars and medical devices to address the substantial unmet medical needs in the CKM syndrome area. As of the latest practicable date, the Company had six innovative drugs — Xinlitan (approved in 2013), Fulitan (approved in 2024), Xinliting (approved in 2024), Xinchaotuo (approved in 2025), Fulian (approved in 2025) and Ennaluo (initially approved in 2023, with an expanded indication approved in 2025). The proportion of innovative drug sales revenue in total drug sales revenue increased from 30.1% in 2023 to 37.7% in 2024 and further to 52.1% in 2025; for the six months ended 30 June 2026, the proportion was 54.8%, up from 50.5% in the corresponding period of 2025.

TENCENT MUSIC-SW (01698.HK): Prices USD 1 billion senior unsecured notes offering in two tranches

Thu, 03 Sep 2026 23:54:10 GMT

NewTimeSpace News: On 4 September 2026, Tencent Music Entertainment Group (stock code: 01698) announced that on 3 September 2026 (US Eastern Time), the Company announced the public offering of senior unsecured notes with an aggregate principal amount of USD 1,000 million, comprising USD 500 million notes with a coupon of 5.050% due in 2031 and USD 500 million notes with a coupon of 5.650% due in 2036. The notes are registered under the US Securities Act and are expected to be listed on the Hong Kong Stock Exchange, and the Company expects to complete the offering on or around 10 September 2026 (US Eastern Time), subject to customary closing conditions.

After deducting underwriting discounts and commissions and estimated offering expenses, the Company expects to receive net proceeds of approximately USD 991.9 million, which it intends to use for general corporate purposes, including refinancing of offshore indebtedness and share repurchases. The joint bookrunners of the offering are J.P. Morgan Securities LLC, Goldman Sachs (Asia) L.L.C. and The Hongkong and Shanghai Banking Corporation Limited, and the joint lead managers are UBS AG Hong Kong Branch, Bank of China Limited and Mitsubishi UFJ Securities (Asia) Limited; the Company entered into an underwriting agreement with the underwriters on 3 September 2026 (US Eastern Time).

The Company has filed with the US Securities and Exchange Commission an automatic shelf registration statement on Form F-3 and the relevant preliminary prospectus supplement, and will apply to the Hong Kong Stock Exchange for approval to list and trade the notes by way of debt issue to professional investors only (having received the Stock Exchange's confirmation of the eligibility of the notes for listing). The Company noted that, as the conditions to the completion of the underwriting agreement may not be satisfied and the underwriting agreement may be terminated upon the occurrence of certain events, there is no assurance that the offering will be completed.

ASYMCHEM (06821.HK): 1,027,575 A-Share Restricted Shares under First Release Tranche of 2025 Incentive Plan to Become Tradable on September 7

Thu, 03 Sep 2026 11:52:51 GMT

NewTimeSpace News: On September 3, 2026, Asymchem Laboratories (Tianjin) Co., Ltd. (stock code: 06821) issued an overseas regulatory announcement reproducing the full text of its announcement published on the Shenzhen Stock Exchange website. The announcement showed that 1,027,575 A shares under the first release tranche of the initial grant of the company's 2025 A-share restricted share incentive plan will be released from trading restrictions, representing 0.3087% of the company's current total A-share capital (SZSE: 002821) and 0.2849% of its total A+H share capital, involving 540 grantees, with the released shares scheduled to be listed for trading on September 7, 2026.

The board of directors passed a resolution at the 13th meeting of the fifth board of directors held on August 24, 2026, approving that the release conditions for the first release period had been satisfied. The initial grant was registered on June 5, 2025, with 4.2733 million restricted shares actually granted to 561 grantees, and the reserved grant was registered on November 27, 2025, with 291,400 shares granted to 137 grantees. The first lock-up period ran from June 5, 2025 to June 4, 2026, and the first sales restriction period from June 5, 2026 to September 4, 2026; upon expiry of the sales restriction period, if the company's overall market value performance reaches the preset target, the restricted shares can be released in accordance with the prescribed ratios from September 7, 2026.

For the company-level performance assessment, the company achieved revenue of RMB 6.670 billion in the assessment year of 2025 for the first release period, up 16.78% from 2024 calculated at constant exchange rates, satisfying performance target A, with none of the adverse circumstances at either company or grantee level occurring; all 540 grantees achieved Grade A in their individual performance assessments. Upon completion of the release, the company's restricted shares under the equity incentive plan will decrease from 4,353,200 shares to 3,325,625 shares, while its unrestricted tradable A shares will increase to 318,071,433 shares, lifting their proportion from 87.91% to 88.19% of total share capital, with total share capital unchanged at 360,663,470 shares.

View announcement.

CMS (00867.HK): China NDA Approval for Ruxolitinib Phosphate Cream in Atopic Dermatitis Adds a Second Indication

Thu, 03 Sep 2026 10:45:49 GMT

NewTimeSpace News: On September 3, 2026, China Medical System Holdings Limited (stock code: 00867) announced that the New Drug Application (NDA) of ruxolitinib phosphate cream (Bailutuo) for mild-to-moderate atopic dermatitis (AD), developed by its subsidiary Dermavon Holdings Limited (Dermavon), an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, had been approved by the National Medical Products Administration (NMPA) on September 2, 2026, with the drug registration certificate obtained on September 3. The NDA was included in the priority review list for pediatric-friendly new products, dosage forms and specifications matching children's physiological characteristics, which shortened the review cycle.

The product is indicated for the short-term and non-continuous chronic topical treatment of mild-to-moderate AD in immunocompetent children aged 2 years and above and adults, where other topical therapies are inadequately controlled or not recommended. In a Phase III clinical study in China, 63.0% of patients treated for 8 weeks achieved an Investigator's Global Assessment (IGA) score of 0 or 1 with an improvement of at least 2 points from baseline, versus 9.2% for placebo (P<0.001), and 78.0% achieved at least a 75% improvement in the Eczema Area and Severity Index (EASI 75), versus 15.4% for placebo (P<0.001).

In January 2026, ruxolitinib phosphate cream received China NDA approval as the first topical JAK inhibitor approved in China for vitiligo, and the AD approval extends the product to a second indication. It is estimated that China had more than 54 million AD patients in 2024, with mild-to-moderate cases accounting for 98%, or more than 52.5 million patients. Dermavon has built a comprehensive treatment-plus-care solution for AD, spanning Bailutuo (mild-to-moderate disease), comekibart injection (MG-K10) (moderate-to-severe disease), oral small-molecule targeted drug CMS-D001 (moderate-to-severe disease) and the Heling soothing product line, which is expected to synergize with Dermavon's commercialized innovative drug ILUMETRI (tildrakizumab injection) and exclusive drug Hirudoid (mucopolysaccharide polysulfate cream) in expert networks and market resources.

On December 2, 2022, the group through Dermavon entered into a collaboration and license agreement with Incyte, obtaining exclusive rights to develop, register and commercialize ruxolitinib phosphate cream in Mainland China, Hong Kong SAR, Macao SAR, the Taiwan region and 11 Southeast Asian countries, together with non-exclusive rights to manufacture the product within the territory. Incyte retains global development and commercialization rights and markets the product as Opzelura in the United States and Europe, where it was the first topical JAK inhibitor approved by the US FDA.

View announcement.

HK Stock Connect Daily Report: HUTCHMED Surged Over 14%, SHEIN-W Hit a Fresh Low, Baidu Inclusion Expectations Heat Up - 20260903

Thu, 03 Sep 2026 10:30:27 GMT

I. Market Overview

On September 3, Hong Kong stocks opened higher but closed lower. The Hang Seng Index fell 0.39% to 25,213.31 points, the Hang Seng TECH Index dropped 1.08%, and the Hang Seng China Enterprises Index declined 0.77%. Full-day turnover reached HKD 199.38 billion, continuing to shrink from the previous session.

On the trading floor, non-ferrous metals including gold rallied against the market trend: TONGGUAN GOLD (00340) rose 9.2% and LINGBAO GOLD (03330) gained 5.75%, as soft US ADP employment data eased rate-hike expectations. Innovative drug plays extended their gains, with HUTCHMED (00013) jumping 14.32% after reaching a licensing collaboration with GSK that includes an upfront payment of USD 110 million and potential milestone payments of up to nearly USD 1.3 billion; SBP GROUP (01177) rose 6.27%. Shipping stocks performed well, with COSCO SHIP ENGY (01138) up 6.49% as geopolitical disruptions underpinned the risk premium for crude tanker shipping. Internet stocks closed lower across the board: ALIBABA-W fell over 2%, and TRIP.COM-S (09961) declined 5.41%. SHEIN-W (00625) slid 8.7% to hit a fresh low.

Southbound capital recorded net purchases of HKD 3.395 billion during the day, of which the Shanghai leg of southbound Stock Connect saw net purchases of HKD 698 million and the Shenzhen leg net purchases of HKD 2.697 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainer 1	02575.HK	XUANZHUBIO-B	18.23	11.12	1.48
Gainer 2	02255.HK	HAICHANG HLDG	15.57	0.25	1.90
Gainer 3	00013.HK	HUTCHMED	14.32	21.88	7.78
Gainer 4	02687.HK	ABLE DIGITAL	12.70	362.00	0.96
Gainer 5	09903.HK	ILUVATAR COREX	9.23	402.20	7.81
Loser 5	02192.HK	MEDLIVE	-5.34	7.01	0.14
Loser 4	02477.HK	WELLCELL HOLD	-5.45	0.21	0.41
Loser 3	02652.HK	CF PHARMTECH	-7.09	11.80	0.30
Loser 2	02889.HK	PATEO	-8.82	142.70	0.93
Loser 1	03268.HK	MEIG	-9.58	19.17	0.46

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	00700.HK	TENCENT	45.75	2.88	-1.19
2	00100.HK	MINIMAX-W	38.30	4.11	3.62
3	09988.HK	ALIBABA-W	36.00	-7.60	-2.18
4	06869.HK	YOFC	33.78	4.64	-3.19
5	02513.HK	Z.AI	27.82	2.40	-0.81
6	01888.HK	KB LAMINATES	25.13	-1.10	3.18
7	00981.HK	SMIC	18.34	-1.48	-0.29
8	01810.HK	XIAOMI-W	16.31	3.75	-2.21
9	02269.HK	WUXI BIO	8.58	3.46	2.97
10	00148.HK	KINGBOARD HLDG	7.77	-1.83	-0.10

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainer 1	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	3.35	7.42
Gainer 2	159570	China Universal CNI HK Equities Innovative Drugs ETF	3.35	21.42
Gainer 3	159297	China Southern CNI HK Equities Innovative Drugs ETF	3.31	2.46
Gainer 4	159286	Penghua CNI HK Equities Innovative Drugs ETF	3.23	0.90
Gainer 5	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	3.17	6.78
Loser 5	159040	Penghua CSI HK Equities Internet ETF	-1.33	0.02
Loser 4	520630	GF CSI HK Equities Internet ETF	-1.39	0.05
Loser 3	513770	Hwabao CSI HK Equities Internet ETF	-1.45	2.74
Loser 2	520910	ChinaAMC CSI HK Equities Internet ETF	-1.45	0.23
Loser 1	159792	Fullgoal CSI HK Equities Internet ETF	-1.60	10.81

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	21.42	9.37	3.35
2	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index	15.71	71.22	-0.21
3	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	10.81	3.00	-1.60
4	513750	GF CSI HK Connect Financials (ex Banks) Thematic ETF	CSI HK Connect Financials (ex Banks) Thematic Index	10.58	8.27	1.81
5	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	10.10	13.72	2.88
6	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	7.55	12.18	2.79
7	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	7.42	10.52	3.35
8	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	6.78	21.08	3.17
9	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	Hang Seng HK Equities Innovative Drugs And Health Care Index	5.35	15.74	2.73
10	520700	Wanjia CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	5.04	66.66	2.91

IV. Industry and Corporate Updates

1. Baidu completes dual primary listing conversion; inclusion in Stock Connect possible as early as September 7

On September 1, Baidu (09888.HK) announced that its voluntary conversion of its secondary listing status on The Stock Exchange of Hong Kong from secondary to dual primary listing had taken effect, with the "S" marker removed from its share short name. Market analysis, based on current rules and review cycles, suggests Baidu could be included in Stock Connect as early as September 7. Group CFO He Haijian said that, drawing on past cases, southbound capital could flow in within days to a week, with incremental inflows of 10% to 15% expected. Morgan Stanley forecasts southbound inflows of USD 3 billion to 6.8 billion over the first 6 to 12 months after inclusion. Baidu is a potential Stock Connect constituent.

2. Moonshot AI reportedly files confidentially with HKEX to kick off Hong Kong IPO process

According to market sources, Moonshot AI, a leading domestic developer of large language models, confidentially filed its A1 with the Hong Kong Stock Exchange this week, formally initiating its Hong Kong IPO process. The company is advancing a new funding round at a pre-money valuation of USD 50 billion, which may be its final round before the IPO. Kimi declined to comment on the rumors. If listed successfully, the company could become a potential Stock Connect constituent.

3. MANYCORE TECH added to Hang Seng Composite Index, effective September 7; inclusion expectations heat up

On August 21, Hang Seng Indexes Company announced the results of its semi-annual index review, with MANYCORE TECH (00068.HK) officially added as a constituent of the Hang Seng Composite Index. The related changes will be implemented after the market close on September 4 and take effect on September 7. Inclusion in the Hang Seng Composite Index is a core prerequisite for entering the Stock Connect eligible universe. The company posted H1 revenue of RMB 405 million, a record-high gross margin of 83%, and adjusted net profit of RMB 55.42 million, up 211% year on year; revenue from new AI applications and new products grew 177% year on year.

4. CHINAGOLDINTL added to Hang Seng High Beta Index and Hang Seng SCHK Central SOEs Quality Index, effective September 7

On September 3, CHINAGOLDINTL (02099.HK) announced its inclusion in the Hang Seng High Beta Index and the Hang Seng SCHK Central SOEs Quality Index. The related changes will be implemented after the market close on September 4 and take effect on September 7. The Hang Seng SCHK Central SOEs Quality Index takes central state-owned enterprises as its stock selection universe, and all of its constituents are eligible for Stock Connect trading. CHINAGOLDINTL is a Stock Connect constituent.

5. LONGSYS subscription closes today; margin financing oversubscribed 26 times; listing expected September 8

On September 3, the public offering of semiconductor memory maker LONGSYS (09976.HK) closed today. The public tranche recorded HKD 17.05 billion in margin financing subscriptions, representing oversubscription of 26.2 times against the public fundraising amount of HKD 630 million. The company plans to offer 26,077,800 H shares globally at a maximum offer price of HKD 240.6 per share, in board lots of 50 shares, with listing expected on September 8.

V. Market Notes

Eligible securities list adjustment announcement

No recent announcements.

Trading calendar

No approaching market closure days.

Hong Kong AI Concept Stock Daily：Most AI chip and large-model names under pressure; Iluvatar CoreX (09903.HK) rose 9.23% against the trend-20260903

Thu, 03 Sep 2026 10:02:33 GMT

I. Market Overview

On September 3, 2026, the three major Hong Kong indices opened higher but closed lower: the Hang Seng Index fell 0.39%, the Hang Seng TECH Index fell 1.08%, and the Hang Seng China Enterprises Index fell 0.77%. The Hang Seng Index's full-day turnover was HK$199.4 billion, and southbound funds recorded a net inflow of HK$3.395 billion. AI concept stocks showed a divergent performance on the day, with the intelligent-driving direction broadly strengthening, while the AI chip and large-model directions were mostly under pressure.

The large-model direction mostly weakened, with MINIMAX-W (00100.HK) rising 3.62% against the trend, KUAISHOU-W (01024.HK) falling 2.62%, and Z.AI, Baidu Group-W, TENCENT, ALIBABA-W, and MEITUAN-W following the declines.

In the AI chip direction, Iluvatar CoreX (09903.HK) rose 9.23%, with HUA HONG GRACE following the gains. BIREN TECH (06082.HK) fell 2.82%, with SMIC, MONTAGE TECHNOLOGY, and GIGADEVICE following the declines.

In the intelligent-driving direction, PONY-W (02026.HK) rose 5.11%, WERIDE-W (00800.HK) rose 2.88%, and HORIZONROBOT-W and ROBOSENSE followed the gains. BLACK SESAME (02533.HK) fell 3.40%.

In the embodied intelligence direction, UBTECH ROBOTICS (09880.HK) edged down 0.06%, and XIAOMI-W (01810.HK) fell 2.21%.

II. Market Performance of Representative AI Stocks

Stock Code	Company Name	Closing Price (HKD)	Change(%)	Sector / Concept
09903.HK	ILUVATAR COREX	402.200	9.23	AI Chips
02026.HK	PONY-W	55.500	5.11	Autonomous Driving
00100.HK	MINIMAX-W	355.000	3.62	LLM
00800.HK	WERIDE-W	15.360	2.88	Autonomous Driving
01347.HK	HUA HONG GRACE	119.800	1.96	AI Chips
09660.HK	HORIZONROBOT-W	4.370	1.51	Autonomous Driving
02498.HK	ROBOSENSE	17.590	1.44	Autonomous Driving
09880.HK	UBTECH ROBOTICS	79.100	-0.06	Embodied AI
00981.HK	SMIC	68.050	-0.29	AI Chips
02513.HK	Z.AI	1,108.000	-0.81	LLM
09888.HK	BIDU-SW	91.500	-0.92	LLM
03986.HK	GIGADEVICE	466.800	-1.14	AI Chips
00700.HK	TENCENT	433.000	-1.19	LLM
06809.HK	MONTAGETECH	258.400	-1.30	AI Chips
03690.HK	MEITUAN-W	77.650	-1.40	LLM
09988.HK	BABA-SW	107.500	-2.18	LLM
01810.HK	XIAOMI-W	27.440	-2.21	Embodied AI
01024.HK	KUAISHOU-W	32.760	-2.62	LLM
06082.HK	BIRENTECH	42.080	-2.82	AI Chips
02533.HK	BLACK SESAME	10.240	-3.40	Autonomous Driving

Data Source: HKEX. For reference only, not investment advice. Data as of market close on September 3, 2026.

III. AI Industry & Corporate Developments

1. Kimi API now natively supports Codex and Claude Code

On September 2, Moonshot AI announced that, to meet users' need to connect Kimi API within Codex and Claude Code, Kimi API now supports OpenAI's Responses API format and also supports Anthropic's Messages API format. Users of Codex or Claude Code can directly connect to models such as kimi-k3, kimi-k2.7-code-highspeed, kimi-k2.7-code, and kimi-k2.6 via a custom model provider, without converting formats or using a local proxy.

2. Anthropic to release a new version of its AI model Fable

On September 2, it was reported that Anthropic will release a new version of its AI model Fable. The company said Fable 5.1 performs better on programming and scientific-research tasks while also costing less. Anthropic stated that Fable 5.1's per-token price for enterprise users will remain consistent with Fable 5, but it will lower the charge when the model re-invokes previously processed information. The company said the price for this step will be cut by 75%, thereby "significantly reducing" the model's overall operating cost.

3. Google launches two new Gemini models, strengthening programming and cybersecurity capabilities

On September 2, Google officially launched two AI models, Gemini 3.8 Flash and Gemini 3.8 Flash Cyber. Gemini 3.8 Flash focuses on optimizing software engineering, AI agents, and multi-step complex reasoning, with pricing maintained at the previous generation's level—delivering performance upgrades without a price increase. Gemini 3.8 Flash Cyber is a cybersecurity-specific model that can automatically discover vulnerabilities and generate remediation patches, and is made available through the Fairwind program to government agencies, critical infrastructure operators, and software maintenance organizations.

4. Tencent WorkBuddy announces platform launch, to fully open Agent foundation capabilities

On September 2, Tencent WorkBuddy announced that its open platform (open.WorkBuddy.cn) has officially launched, with over 100 ecosystem partners introduced in the first batch, opening up underlying Agent capabilities to smart hardware, industry applications, developers, and others. To date, brands including Plaud, Rokid, Insta360, iFLYTEK, Anker, Hollyland, and JD Jingzao have launched co-branded smart hardware, covering more than 20 fields such as finance, law, healthcare, education, and public welfare.

5. NVIDIA close to acquiring AI company Hugging Face for US$14 billion

On September 2, it was reported that NVIDIA is in advanced talks to acquire AI startup Hugging Face, in a deal that could be worth about US$14 billion. The report said NVIDIA's retention package for acquiring Hugging Face is valued at US$12.9 billion.

IV. Profiles of Representative AI Concept Stocks

Company Name	Stock Code	Industry Position	Main Product Lines & Business Overview
MINIMAX-W	00100.HK	A top-tier player dedicated to omni-modal Artificial General Intelligence (AGI)	The company continuously iterates its video generation model matrix and has partnered with mainstream domestic and overseas chip manufacturers and inference platforms to complete underlying adaptations. The total monthly active users (MAU) of its B2C and B2B LLM applications, along with multimodal API call volumes, maintain rapid growth, further broadening its computing power ecological layout.
PONY-W	02026.HK	Global commercialization leader in L4 autonomous mobility and logistics	The first autonomous driving company in China to secure fully driverless Robotaxi commercial operation permits across all four top-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen). Core operations span autonomous ride-hailing (Robotaxi) and freight services (Robotruck), with Robotaxi deployments across 9 countries and public operations in overseas markets including Croatia, Qatar, Singapore, and South Korea. Targeting a global fleet exceeding 3,000 vehicles across 20+ cities by 2026, the company has achieved positive unit economics per vehicle.
ILUVATAR COREX	09903.HK	Domestic general-purpose GPU pioneer & builder of full-scenario AI compute bases	Established in 2015, it is among the earliest domestic vendors to achieve mass production of general-purpose GPUs. Product lines cover training, inference, and edge computing across the Tiangai, Zhikai, and Tongyang series. In July 2026, it launched its next-gen flagship Tiangai 300 at WAIC, matching the Nvidia Hopper architecture. As of late 2025, it served 340+ clients across 30+ industries, generating core GPGPU revenue of ~RMB 923 million (+149.6% YoY).
HORIZONROBOT-W	09660.HK	China's leading intelligent driving computing solution provider and full‑stack vehicle intelligence enabler	Founded in 2015, it offers ADAS and high‑level autonomous driving solutions. Core products include the Journey-series in-car AI chips (cumulative shipments exceeding 10 million units), the HSD full‑scenario urban driving solution, and the "Starry 6P" cockpit‑driving integrated vehicle intelligence chip. In 2025, it held a 47.7% market share in domestic ADAS for independent brands, with full‑year revenue of RMB 3.758 billion, up 57.7% YoY.
HUA HONG GRACE	01347.HK	Global leader in specialty process wafer foundry	A world‑leading specialty process wafer foundry, the company operates 8‑inch and 12‑inch production lines serving new energy vehicles, industrial control, and data center power management. It provides customized manufacturing in power devices, embedded non‑volatile memory, analog ICs, and power management chips, with multiple automotive‑grade certifications and sustained high capacity utilization.

NewTimeSpace | Hong Kong Market Close: The three major indices opened higher but closed lower, with the Hang Seng Index ending down 0.39%, and themes such as non-ferrous metals and non-bank financials rising against the trend

Thu, 03 Sep 2026 09:35:42 GMT

NewTimeSpace (newtimespace.com) reported that on September 3, 2026, the three major Hong Kong indices opened higher but closed lower: the Hang Seng Index fell 0.39%, the Hang Seng TECH Index fell 1.08%, and the Hang Seng China Enterprises Index fell 0.77%. The Hang Seng Index's full-day turnover was HK$199.4 billion, lower than the previous trading day. Southbound funds recorded a net inflow of HK$3.395 billion.

On the market breadth, by sector: themes such as non-ferrous metals, non-bank financials, and transportation rose against the trend, while themes such as coal, paper and packaging, and consumer discretionary retail led the declines.

Among the Hang Seng Index constituent stocks, 42 rose and 50 fell. On the downside, TRIP.COM-S fell 5.41%, CHOW TAI FOOK fell 4.22%, and WHARF REIC fell 3.28%. On the upside, SBP GROUP rose 6.27%, CSPC PHARMA rose 4.80%, and CHINA RES MIXC rose 3.59%.

Among the Hang Seng TECH Index constituent stocks, 7 rose and 23 fell. On the downside, TONGCHENGTRAVEL fell 4.50%, JD HEALTH fell 2.70%, and KUAISHOU-W fell 2.62%. On the upside, MINIMAX-W rose 3.62%, HUA HONG GRACE rose 1.96%, and HAIER SMART HOME rose 1.53%.

Among the Stock Connect constituent stocks, XUANZHUBIO-B surged 18.23%, HAICHANG HLDG surged 15.57%, and ABLE DIGITAL surged 12.70%. MeiG Intelligent Link fell 9.58%; PATEO fell 8.82%; and CF PHARMTECH fell 7.09%.

In its Hong Kong market outlook, China Zheshang International Financial Holdings stated that, on fundamentals: the domestic economy remains in a bottoming-out phase, with severe internal structural divergence within the economy; on policy: technological innovation and expanding domestic demand are the focus of subsequent policies; on liquidity: expectations of US rate cuts are under short-term pressure, while southbound funds increased their positions against the market trend this week; on sentiment: the market has pulled back from a phase high, and short-term market sentiment has turned cautious.

In terms of sector allocation, it favors sectors with relatively strong prosperity that also benefit from favorable policies, such as New Energy, innovative drugs, and AI technology; the undervalued central and state-owned enterprise (SOE) dividend sector with steady earnings and share prices that benefit from favorable policies; and Hong Kong local banks, telecom, and utility dividend stocks whose fundamentals are relatively independent and that benefit from the rate-cut cycle. (Source: China Zheshang International Financial Holdings, "Hong Kong Market Strategy Weekly Report," September 3, 2026)

HK shares ETFs Daily Report : Gold Miners Surged Nearly 4%; China Internet and Hang Seng TECH Came Under Pressure Again - 20260903

Thu, 03 Sep 2026 08:33:03 GMT

NewTimeSpace News: On September 3, 2026, the HK shares ETFs market showed broad gains in gold miner, Taiwan, Japan and biopharma themes, while China internet, high-dividend yield and Hang Seng TECH ETFs pulled back slightly, with market sentiment recovering markedly from the previous session.

Gold miner and Taiwan themes performed strongly during the session. E Fund (HK) Solactive Global Gold Miner Select Index ETF (2824.HK) rose 3.98%, the largest gain; iShares Core MSCI Taiwan Index ETF (3074.HK) advanced 3.24%; Global X Japan Global Leaders ETF (3150.HK) rose 2.22%; E Fund (HK) Solactive Biopharma Select Index ETF (3186.HK) gained 1.96%; Pando Blockchain ETF (3112.HK) rose 1.90%; ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069.HK) and CSOP Hang Seng Biotech ETF (3174.HK) both advanced 1.72%; Hang Seng Japan TOPIX 100 Index ETF (3410.HK) rose 1.67%; Global X China Biotech ETF (2820.HK) gained 1.47%; and CSOP Nikkei 225 Index ETF (3153.HK) rose 1.43%. Overall, gold miner, Taiwan, Japan and biopharma themes formed an evident rebound linkage, with all of the top-10 gainers up more than 1.4%.

HK shares ETFs Top 10 Gainers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	2824.HK	E Fund (HK) Solactive Global Gold Miner Select Index ETF	3.98	--	E Fund Asset Management (Hong Kong) Limited
2	3074.HK	iShares Core MSCI Taiwan Index ETF	3.24	MSCI Taiwan Index	BlackRock Asset Management North Asia Limited
3	3150.HK	Global X Japan Global Leaders ETF	2.22	FactSet Japan Global Leaders Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
4	3186.HK	E Fund (HK) Solactive Biopharma Select Index ETF	1.96	--	E Fund Asset Management (Hong Kong) Limited
5	3112.HK	Pando Blockchain ETF	1.90	--	Pando Limited
6	3069.HK	ChinaAMC Hang Seng Hong Kong Biotech Index ETF	1.72	Hang Seng Hong Kong-Listed Biotech Index	China Asset Management (Hong Kong)
7	3174.HK	CSOP Hang Seng Biotech ETF	1.72	Hang Seng Hong Kong-Listed Biotech Index	CSOP Asset Management Limited
8	3410.HK	Hang Seng Japan TOPIX 100 Index ETF	1.67	TOPIX Total Return Index	Hang Seng Investment Management
9	2820.HK	Global X China Biotech ETF	1.47	Solactive China Biotech Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
10	3153.HK	CSOP Nikkei 225 Index ETF	1.43	--	CSOP Asset Management Limited
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 3, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

On the downside, China internet and Hang Seng TECH ETFs led the declines, though losses were modest overall. ICBC UBS KraneShares KWEB CSI China Internet ETF (3102.HK) fell 1.59%, the biggest drop; Global X Asia Pacific High Dividend Yield ETF (3116.HK) declined 1.32%; Global X Hang Seng TECH ETF (2837.HK) fell 1.25%; ChinaAMC CSI 300 Index ETF (3188.HK) declined 1.20%; CMS Hang Seng Tech Index ETF (3423.HK) fell 1.17%; CSOP Hang Seng Tech Index ETF (3033.HK) declined 1.13%; Hang Seng TECH Index ETF (3032.HK) fell 1.06%; iShares Hang Seng TECH ETF (3067.HK) declined 1.05%; ChinaAMC Hang Seng Tech Index ETF (3088.HK) fell 0.96%; and Hang Seng FTSE China 50 Index ETF (2838.HK) declined 0.90%. China internet, high-dividend yield and Hang Seng TECH ETFs came under pressure during the session, but no decline exceeded 1.6%.

HK shares ETFs Top 10 Decliners
No.	Code	Name	Change (%)	Tracking Index	Manager
1	3102.HK	ICBC UBS KraneShares KWEB CSI China Internet ETF	-1.59	CSI Overseas China Internet Index	ICBC Credit Suisse Asset Management (International) Company Limited
2	3116.HK	Global X Asia Pacific High Dividend Yield ETF	-1.32	Solactive Asia Pacific High Dividend Yield Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
3	2837.HK	Global X Hang Seng TECH ETF	-1.25	Hang Seng TECH Index	Mirae Asset Global Investments (Hong Kong)
4	3188.HK	ChinaAMC CSI 300 Index ETF	-1.20	CSI 300 Index	China Asset Management (Hong Kong)
5	3423.HK	CMS Hang Seng Tech Index ETF	-1.17	Hang Seng TECH Index	CMS Asset Management (HK) Co., Limited
6	3033.HK	CSOP Hang Seng Tech Index ETF	-1.13	Hang Seng TECH Index	CSOP Asset Management Limited
7	3032.HK	Hang Seng TECH Index ETF	-1.06	Hang Seng TECH Index	Hang Seng Investment Management
8	3067.HK	iShares Hang Seng TECH ETF	-1.05	Hang Seng TECH Index	BlackRock Asset Management North Asia Limited
9	3088.HK	ChinaAMC Hang Seng Tech Index ETF	-0.96	Hang Seng TECH Index	China Asset Management (Hong Kong)
10	2838.HK	Hang Seng FTSE China 50 Index ETF	-0.90	FTSE China 50 Index	Hang Seng Investment Management
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 3, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

NewTimeSpace Research data showed that on September 3, 2026, the HK shares ETFs market featured a rotation in which gold miner and regional technology themes strengthened while Hang Seng TECH and China internet ETFs came under pressure. Gold miner, Taiwan, Japan and biopharma themes saw concentrated rebounds and led the gains, whereas China internet, high-dividend yield and Hang Seng TECH ETFs pulled back slightly. Market hotspots recovered markedly from the previous session's extremely depressed state, with gold miner and Japan/Taiwan themes becoming the day's main lines and biopharma extending its rebound; Hang Seng TECH and China internet ETFs, however, still face some adjustment pressure.

Autonomous Driving Concept Stocks Watch | BIDU-W (09888.HK) Edges Lower in Afternoon Session; MIIT Outlines Four Key Priorities for ICV & New‑Energy Vehicles in the 15th Five‑Year Plan

Thu, 03 Sep 2026 07:45:20 GMT

NewTimeSpace News: On September 3, 2026,BIDU-W(09888.HK) drifted lower in the afternoon. As of 15:27, the stock traded at HK$91.50, down 0.92%.

On the news front, Baidu’s voluntary conversion from secondary listing to dual‑primary listing on the Hong Kong Stock Exchange took effect on September 1. Baidu is now dual‑primary‑listed on both the Hong Kong Stock Exchange and Nasdaq Global Select Market.

According to Shanghai Securities, the Ministry of Industry and Information Technology (MIIT) has defined four deployment priorities for new‑energy vehicles under the 15th Five‑Year Plan. As reported by Autohome News, on August 26, the State Council Information Office held a press conference in the series“Kick‑off of the 15th Five‑Year Plan”. Xin Guobin, Vice‑Minister of MIIT, stated that the 15th Five‑Year Plan for the Development of Intelligent Connected New‑Energy Vehicle Industry has been formulated, covering product supply quality and supporting‑service provisions.

BIDU-W (09888.HK) Focuses on the R&D of L4 autonomous driving algorithms and the commercialization of unmanned Robotaxis. Leveraged by the ERNIE foundational model and optimized by the Qianfan compute base, its "Apollo Go" autonomous ride-hailing service has achieved large-scale, normalized commercial operations across multiple core cities in China, with cumulative autonomous test mileage exceeding hundreds of millions of kilometers. Through high-frequency, high-confidence real-world road test data cleansing, the company continues to solidify the most robust data asset and algorithmic moat within the HKEX autonomous driving sector.

Shanghai-Shenzhen Stock Connect ETFs Daily Report: Gold Stock ETFs Led Strong Gains; STAR Semiconductors Pulled Back Moderately as Market Sentiment Recovered - 20260903

Thu, 03 Sep 2026 07:39:33 GMT

NewTimeSpace News: On September 3, 2026, the Shanghai-Shenzhen Stock Connect ETFs market showed a broad advance in gold stocks, STAR innovative drugs, energy-storage batteries and robotics, while STAR semiconductor equipment, semiconductor equipment and animal husbandry ETFs pulled back slightly, with market sentiment improving from the previous session as gainers clearly outperformed losers.

Gold stock ETFs performed strongly during the session. Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517400.SH) rose 2.39%, the largest gain; Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520.SH) rose 2.35%; ChinaAMC CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (159562.SZ) advanced 2.16%; and Huaan CSI Shanghai-Shenzhen-Hong Kong Gold Industry Stocks ETF (159321.SZ) gained 2.10%.

SSE STAR innovative drugs and energy-storage battery ETFs rallied in tandem: Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF (589720.SH) rose 1.81%; E Fund CNI New Energy Batteries ETF (159566.SZ) gained 1.75%; and GF CNI New Energy Batteries ETF (159305.SZ) rose 1.65%. In addition, Hwabao WP CSI Non-ferrous Metal ETF (159876.SZ) rose 1.64%; Guotai CSI Oil and Gas Industry ETF (561360.SH) gained 1.63%; and Invesco Great Wall CNI Robot Industry ETF (159559.SZ) rose 1.61%. Overall, gold stocks, SSE STAR innovative drugs and energy-storage batteries formed an evident sector linkage, with all of the top-10 gainers up more than 1.6%.

Shanghai-Shenzhen Stock Connect ETF Top 10 Gainers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	517400.SH	Guotai CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF	2.39	CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index	Guotai Asset Management
2	517520.SH	Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF	2.35	CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index	Maxwealth Fund Management
3	159562.SZ	ChinaAMC CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF	2.16	CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index	China Asset Management
4	159321.SZ	Huaan CSI Shanghai-Shenzhen-Hong Kong Gold Industry Stocks ETF	2.10	CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index	Huaan Fund Management
5	589720.SH	Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF	1.81	SSE STAR Innovative Drugs Index	Guotai Asset Management
6	159566.SZ	E Fund CNI New Energy Batteries ETF	1.75	CNI New Energy Battery Index	E Fund Management
7	159305.SZ	GF CNI New Energy Batteries ETF	1.65	CNI New Energy Battery Index	GF Fund Management
8	159876.SZ	Hwabao WP CSI Non-ferrous Metal ETF	1.64	CSI Non-ferrous Metal Index	Hwabao WP Fund Management
9	561360.SH	Guotai CSI Oil and Gas Industry ETF	1.63	CSI Oil and Gas Industry Index	Guotai Asset Management
10	159559.SZ	Invesco Great Wall CNI Robot Industry ETF	1.61	CNI Robot Industry Index	Invesco Great Wall Fund Management
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onSeptember 3, 2026

On the downside, STAR semiconductor equipment and semiconductor equipment ETFs led the declines, although losses were modest overall. Huatai-PB China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (588710.SH) fell 1.43%, the biggest drop; ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (588170.SH) declined 1.27%; Penghua China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF (589020.SH) fell 1.22%; ChinaAMC CSI Semiconductor Material Equipment Theme ETF (562590.SH) declined 1.14%; Wanjia CSI Semiconductor Material Equipment Theme ETF (159327.SZ) fell 1.09%; E Fund CSI Semiconductor Material Equipment Theme ETF (159558.SZ) declined 0.93%; Guotai CSI Animal Husbandry ETF (159865.SZ) fell 0.91%; China Merchants CSI Semiconductor Industry ETF (561980.SH) declined 0.90%; Penghua CSI Animal Husbandry ETF (159867.SZ) fell 0.89%; and GF CSI Semiconductor Material Equipment Theme ETF (560780.SH) declined 0.89%. STAR semiconductor equipment, semiconductor equipment and animal husbandry ETFs came under pressure during the session, but none of the declines exceeded 1.5%, pointing to limited overall pullback.

Shanghai-Shenzhen Stock Connect ETF Top 10 Losers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	588710.SH	Huatai-PB China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-1.43	SSE STAR Semiconductor Material Equipment Theme Index	Huatai-PineBridge Fund Management
2	588170.SH	ChinaAMC China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-1.27	SSE STAR Semiconductor Material Equipment Theme Index	China Asset Management
3	589020.SH	Penghua China Science And Technology Innovation Board Semiconductor Material Equipment Theme ETF	-1.22	SSE STAR Semiconductor Material Equipment Theme Index	Penghua Fund Management
4	562590.SH	ChinaAMC CSI Semiconductor Material Equipment Theme ETF	-1.14	CSI Semiconductor Material Equipment Theme Index	China Asset Management
5	159327.SZ	Wanjia CSI Semiconductor Material Equipment Theme ETF	-1.09	CSI Semiconductor Material Equipment Theme Index	Wanjia Asset Management
6	159558.SZ	E Fund CSI Semiconductor Material Equipment Theme ETF	-0.93	CSI Semiconductor Material Equipment Theme Index	E Fund Management
7	159865.SZ	Guotai CSI Animal Husbandry ETF	-0.91	CSI Animal Husbandry Index	Guotai Asset Management
8	561980.SH	China Merchants CSI Semiconductor Industry ETF	-0.90	CSI Semiconductor Industry Index	China Merchants Fund Management
9	159867.SZ	Penghua CSI Animal Husbandry ETF	-0.89	CSI Animal Husbandry Index	Penghua Fund Management
10	560780.SH	GF CSI Semiconductor Material Equipment Theme ETF	-0.89	CSI Semiconductor Material Equipment Theme Index	GF Fund Management
Source/Compiled by: Wind / NewTimeSpace Research Institute, as of the close onSeptember 3, 2026

NewTimeSpace Research data showed that on September 3, 2026, the Shanghai-Shenzhen Stock Connect ETFs market featured a rotation in which gold stocks and innovative drugs strengthened while semiconductor equipment ETFs pulled back moderately. Gold stocks, SSE STAR innovative drugs, energy-storage batteries and robotics saw concentrated gains and led the advance, whereas STAR semiconductor equipment, semiconductor equipment and animal husbandry ETFs declined slightly. Market hotspots rotated swiftly from the previous session's military/defense theme to gold stocks and innovative drugs, with gold stock ETFs rallying across the board and SSE STAR innovative drugs and energy-storage battery ETFs also delivering solid performance. Market sentiment recovered from the previous session, though semiconductor equipment ETFs still face some adjustment pressure.

LONGSYS (09976.HK): Public offering closed today, total margin financing of HKD 17.047 billion recorded

Thu, 03 Sep 2026 06:51:01 GMT

NewTimeSpace News: On 3 September 2026, Shenzhen Longsys Electronics Co., Ltd. (stock code: 09976) closed its public offering, with the offering period having run from 31 August to 3 September 2026. As of 12:00 noon on 3 September, total margin financing amounted to HKD 17.047 billion, the public offering size was HKD 627 million, and the actual margin financing multiple was 27.16 times.

In respect of offering details, the Company made a global offering of an aggregate of 26,077,800 shares (comprising 2,607,800 shares under the public offering, representing 10%, and 23,470,000 shares under the international placing, representing 90%), with a maximum offer price of HKD 240.60 per share and each board lot comprising 50 shares, implying an application fee of approximately HKD 12,151.32. Pricing is scheduled for 7 September 2026, with listing expected on 8 September 2026.

In respect of cornerstone investors, a total of 15 cornerstone investors were introduced for the global offering, with an aggregate subscription of approximately 4,926,050 shares; assuming the offer price adjustment option is not exercised, the cornerstone subscription accounts for approximately 18.89% of the total number of offer shares and approximately 1.08% of the issued shares.

AI Chip Concept Stocks Watch | ASMPT (00522.HK) Up 2.67%; Broadcom Predicts AI Chip Sales to Surge Sharply

Thu, 03 Sep 2026 05:50:49 GMT

NewTimeSpace (newtimespace.com) News, on September 3, 2026, the chip theme weakened amid volatility while ASMPT (00522.HK) strengthened against the trend. As of 13:46, the stock was quoted at HKD 161.600, up 2.67%.

On the news front, on September 2, Broadcom predicted that its AI chip sales will surge sharply over the next two years. Chief Executive Officer Hock Tan stated that AI chip revenue will double to approximately USD 115 billion in fiscal year 2027 and soar to USD 230 billion in the next fiscal year.

Sinolink Securities pointed out that in the first half of 2026, the electronics industry's revenue and net profit grew 30.98% and 99.38% year-on-year respectively, with the PCB, semiconductor equipment, and design segments performing particularly prominently. Demand for AI servers and high-speed switches has driven both volume and price higher across the supply chain, while domestic substitution has accelerated; orders in the equipment and core components segments have maintained high growth, and profitability has improved markedly.

ASMPT(00522.HK)Engages in R&D and global sales of semiconductor assembly and packaging equipment, advanced packaging equipment, and surface mount technology. Its 2.5D/3D advanced packaging tools, such as thermo-compression bonding (TCB) machines, have been delivered to multiple leading OSATs, IDMs, and memory manufacturers worldwide for volume production of HBM and chiplet-based chips. The company has publicly disclosed multiple follow-on orders from AI-compute related customers.

Humanoid Robot Concept Stock Watch | XIAOMI-W (01810.HK) Weakens Amid Volatility; Musk Predicts 1 Billion Humanoid Robots Globally Within a Decade

Thu, 03 Sep 2026 05:42:56 GMT

NewTimeSpace (newtimespace.com) News, on September 3, 2026, the robot theme rose amid volatility while XIAOMI-W (01810.HK) weakened. As of 13:33, the stock was quoted at HKD 27.320, down 2.64%.

On the news front, Elon Musk said at the G20 Summit that robotics technology will bring leapfrog growth in productivity. He predicted that within the next decade, the global number of humanoid robots will reach 1 billion units. The output of these robots will be at least five times that of humans. He believes the widespread application of humanoid robots could expand the global economic scale more than tenfold.

Kaiyuan Securities stated that the humanoid robot industry is moving from the technology-exploration stage to a critical period of scaled commercial validation and industrial ecosystem build-out. At the policy level, the "15th Five-Year Plan" explicitly identifies intelligent robots as an important direction of new quality productive forces, driving their empowerment of the digital-intelligent transformation of traditional manufacturing. In the first half of 2026, some companies' robot projects have shifted from sample delivery to mass production, with revenue from DC motors and components surging 202.29% year-on-year, indicating accelerated release of demand for core components. As projects in the industrial equipment field continue to increase, micro special motors for robots are expected to become a key development area for future technology and market, with broad application space.

XIAOMI-W(01810.HK) Leverages its massive AIoT ecosystem network and full-stack proprietary AI algorithms to advance the collaborative deployment of consumer- and industrial-grade embodied AI devices. Algorithms for its CyberOne humanoid robot and CyberDog bionic quadruped robot undergo continuous iteration. The underlying multi-modal machine vision, force-control algorithms, and automated scheduling logic are deeply integrated into the "dark factory" operations and flexible manufacturing workflows of Xiaomi's smart factories, establishing a complete closed-loop model of "algorithm + hardware + proprietary manufacturing application scenarios."

E.VAT MASTER files for listing on HKEX: the world's and China's largest cross-border e-commerce compliance service provider

Thu, 03 Sep 2026 05:14:10 GMT

NewTimeSpace News: On 3 September 2026, VATAI Holdings Limited (E.VAT MASTER) filed its listing application with the Hong Kong Stock Exchange, with CICC and Shenwan Hongyuan Securities (H.K.) Limited acting as joint sponsors. The Company is an AI-driven global cross-border e-commerce compliance service platform. According to CIC, by sales in 2025, the Company was the largest cross-border e-commerce compliance service provider globally and in China, with sales exceeding the combined total of the market participants ranked second to eighth in China in the same year; by 2025 sales, the Company held a market share of 21.5% in China's cross-border e-commerce compliance platform market, leading the industry.

In respect of financials, as of 30 June 2026, the Company had cumulatively served more than 264,000 paying users. During the track record period, the Company's revenue grew 45.9% year on year to RMB 350.5 million in 2024, and 50.8% year on year to RMB 528.5 million in 2025; revenue further grew 65.6% from the six months ended 30 June 2025 to RMB 385.9 million in the corresponding period of 2026.

In respect of operations, the Company has established four business segments, including corporate finance and tax compliance, environmental compliance, product testing and certification, and intellectual property protection (IPP), and operates a one-stop global cross-border compliance platform through seven brands with distinct positioning — VATAI, Maidetong, Xiaomao Chuhai, Lvzhou, VATAi, Yisi Cross-border and Nengbiao Testing — covering seven service lines: VAT+, overseas corporate services, EPR, carbon compliance, responsible persons (RsP), testing inspection and certification (TIC) and IPP; the Company's proprietary cross-border compliance AI agent "Xiao O" provides an intuitive gateway to the platform. As of the latest practicable date, the Company managed over 6,000 active service SKUs covering complex compliance scenarios across these segments in 121 countries and regions, and held 27 categories of global regulatory licences and certifications required for or recognised in its business.

Penghua CSI 800 Securities And Insurance ETF (515630) was last quoted at RMB 1.31, and the CSI 800 Securities And Insurance Index (399966) rose 1.91%

Thu, 03 Sep 2026 02:22:49 GMT

NewTimeSpace (newtimespace.com) News, as of 10:10 on September 3, 2026, the CSI 800 Securities And Insurance Index (399966) rallied strongly by 1.91%, and the Penghua CSI 800 Securities And Insurance ETF (515630) was last quoted at RMB 1.31.

In terms of liquidity, the Penghua CSI 800 Securities And Insurance ETF saw an intraday turnover rate of 2.15% with turnover of RMB 25.767 million. Over a longer horizon, as of September 2, the ETF's average daily turnover over the past year was RMB 49.0483 million.

In terms of scale, the Penghua CSI 800 Securities And Insurance ETF's latest AUM reached RMB 1.181 billion. (Data source: Wind)

Data shows leveraged funds continue to build positions. The Penghua CSI 800 Securities And Insurance ETF's latest margin buy turnover reached RMB 1.7434 million, and its latest margin balance reached RMB 22.6121 million. (Data source: Wind)

As of September 2, the Penghua CSI 800 Securities And Insurance ETF's net value rose 35.15% over the past two years. In terms of return capability, as of September 2, 2026, since inception the ETF's highest single-month return was 35.31%, its longest winning streak was 4 months with a longest rally gain of 27.28%, its average return rate in rising months was 7.00%, its annual profitability percentage was 60.00%, and its 3-year holding profitability probability was 63.17%. As of September 2, 2026, the ETF's annualized excess return over the benchmark over the past three months was 7.71%.

In terms of drawdown, as of September 2, 2026, the Penghua CSI 800 Securities And Insurance ETF's drawdown relative to the benchmark over the past six months was 0.09%.

In terms of fees, the Penghua CSI 800 Securities And Insurance ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%.

In terms of tracking precision, as of September 2, 2026, the Penghua CSI 800 Securities And Insurance ETF's tracking error over the past month was 0.044%.

From a valuation perspective, the CSI 800 Securities And Insurance Index tracked by the Penghua CSI 800 Securities And Insurance ETF (515630) has a latest P/E (TTM) of only 7.65x, at the 12.2% percentile over the past year — meaning its valuation is lower than in over 87.8% of the time over the past year, placing it at a historic low.

The Penghua CSI 800 Securities And Insurance ETF (515630) closely tracks the CSI 800 Securities And Insurance Index. The CSI 800 Securities And Insurance Index, on the basis of the CSI 800 Index, selects the corresponding securities within the securities and insurance industry as index samples, providing investors with more diversified investment instruments.

Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) was last quoted at RMB 2.22, and the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index (931238) gained 2.02%

Thu, 03 Sep 2026 02:14:35 GMT

NewTimeSpace (newtimespace.com) News, as of 10:04 on September 3, 2026, the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index (931238) rallied strongly by 2.02%, and the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) was last quoted at RMB 2.22.

In terms of liquidity, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF saw an intraday turnover rate of 1.54% with turnover of RMB 215 million. Over a longer horizon, as of September 2, the ETF's average daily turnover over the past month was RMB 1.197 billion.

In terms of scale, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's AUM grew by RMB 650 million over the past month, a notable increase. (Data source: Wind)

In terms of shares, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's shares outstanding grew by 579 million shares over the past three months, a notable increase. (Data source: Wind)

Data shows leveraged funds continue to build positions. The Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's latest margin buy turnover reached RMB 61.857 million, and its latest margin balance reached RMB 236 million. (Data source: Wind)

As of September 2, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's net value rose 23.29% over the past year, ranking 559/4326 among index equity funds and placing it in the top 12.92%. In terms of return capability, as of September 2, 2026, since inception the ETF's highest single-month return was 39.65%, its longest winning streak was 4 months with a longest rally gain of 40.27%, its average return rate in rising months was 12.27%, its annual profitability percentage was 100.00%, and its 2-year holding profitability probability was 100.00%. As of September 2, 2026, the ETF's annualized excess return over the benchmark over the past three months was 6.32%.

As of August 28, 2026, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's Sharpe ratio over the past two years was 1.20.

In terms of drawdown, as of September 2, 2026, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's drawdown relative to the benchmark over the past six months was 0.29%.

In terms of fees, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%, a relatively low fee level among comparable funds.

In terms of tracking precision, as of September 2, 2026, the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF's tracking error over the past two months was 0.041%.

From a valuation perspective, the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index tracked by the Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) has a latest P/E (TTM) of only 15.62x, at the 18.29% percentile over the past year—meaning its valuation is lower than in over 81.71% of the time over the past year, placing it at a historic low.

The Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) closely tracks the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index. The CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index selects 50 listed company securities with relatively large market capitalization and businesses involving gold mining, smelting, and sales from the mainland and Hong Kong markets as index samples, to reflect the overall performance of gold industry listed company securities in the mainland and Hong Kong markets.

ANJI MICRO (688019.SH): Files H-share issuance and listing application with HKEX

Wed, 02 Sep 2026 23:59:23 GMT

NewTimeSpace News: On 3 September 2026, Anji Microelectronics Technology (Shanghai) Co., Ltd. (stock code: 688019.SH) announced that on 2 September 2026 it had filed its application for the issuance of H shares and listing on the Hong Kong Stock Exchange in confidential form. The Company had previously approved the relevant resolutions on the issuance of H shares and listing on the Hong Kong Stock Exchange at the fourth meeting of the fourth session of its board of directors held on 13 July 2026 and the second extraordinary general meeting of 2026 held on 5 August 2026.

The Company will complete the filing procedures with the China Securities Regulatory Commission (CSRC) in accordance with relevant laws and regulations. The H-share issuance and listing remains subject to the filing, approval or consent of the CSRC, the Hong Kong Securities and Futures Commission, the Hong Kong Stock Exchange and other relevant authorities, and there remains uncertainty as to whether the necessary filings, approvals or consents will be obtained and the timing thereof; the Company reminded investors to make cautious decisions and be aware of investment risks.

CHINAGOLDINTL (02099.HK): Selected for inclusion in Hang Seng Momentum Index and Hang Seng HK Stock Connect SOE Quality Index

Wed, 02 Sep 2026 23:41:52 GMT

NewTimeSpace News: On 2 September 2026 (Vancouver time), China Gold International Resources Corp. Ltd. (stock code: 02099) announced that the Company has been selected for inclusion in the Hang Seng Momentum Index and the Hang Seng HK Stock Connect SOE Quality Index. The change will be implemented after the market close on Friday, 4 September 2026, and will take effect from Monday, 7 September 2026.

The Hang Seng Momentum Index aims to reflect the overall performance of securities listed in Hong Kong with the highest sensitivity to stock market movements, comprising 40 large- and mid-cap listed companies with the highest sensitivity to market volatility, constructed using a beta-weighted methodology with individual constituent caps. The Hang Seng HK Stock Connect SOE Quality Index uses central SOEs as its stock selection universe, screening in targets ranked in the top 40% by quality score with weight-tilting adjustments, with all constituents eligible for Stock Connect trading. The Company's simultaneous inclusion in two Hang Seng thematic indices with distinct positioning is regarded by the Company as dual recognition by the international index compiler of its share price elasticity, market trading liquidity, governance standards, earnings stability and dividend return capability, which will help broaden its coverage of domestic and overseas investors.

Mr. Hou Chenguang, Chairman and Chief Executive Officer of the Company, said that the Company will steadily advance key projects including the Jiama Mine expansion and the underground mining construction at the Changshanhao Gold Mine, continuously improving corporate governance and enhancing shareholder returns while maintaining steady earnings growth.

KEYMED BIO-B (02162.HK): Exclusive License Agreement for Stapokibart Covering 18 Countries and Regions Including Southeast Asia and Central Asia

Wed, 02 Sep 2026 13:40:42 GMT

NewTimeSpace News: On 2 September 2026, Keymed Biosciences Inc. (stock code: 02162.HK) announced, on a voluntary basis, that the Company had signed an exclusive license agreement with multinational pharmaceutical company Aeira Pte. Ltd. (Aeira) to collaborate on the registration and commercialization of Stapokibart injection (trade name: Kangyueda), an IL-4Rα-targeting monoclonal antibody developed in-house by the Company, in Southeast Asia and Central Asia.
Under the agreement, Keymed will receive an upfront payment, milestone payments upon approval of marketing applications in different countries and commercialization milestone payments, and is entitled to royalties of up to high-double-digit rates calculated on the net sales of the product in the licensed territories.
Aeira will be responsible for the regulatory filings and commercialization of Stapokibart in 11 countries in Southeast Asia (Brunei Darussalam, Cambodia, Indonesia, the Lao People's Democratic Republic, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor-Leste and Vietnam), 5 countries in Central Asia (Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan), and the Hong Kong Special Administrative Region and the Macao Special Administrative Region — 18 countries and regions in total. Keymed will continue to be responsible for the manufacture and supply of Stapokibart for Aeira.
Stapokibart (trade name: Kangyueda, R&D codename: CM310) is the first domestically developed IL-4Rα antibody drug granted marketing approval by the NMPA, with its indications for moderate-to-severe atopic dermatitis in adults, chronic rhinosinusitis with nasal polyposis and seasonal allergic rhinitis approved for marketing in September 2024, December 2024 and February 2025, respectively. The collaboration marks an important milestone in Keymed's internationalization strategy for innovative biologics, leveraging the partner's unique commercial networks and registration experience in Southeast Asia and Central Asia to accelerate the launch and commercialization of Stapokibart in these regions.

View announcement.

VIVA GOODS (00933.HK): Acquires Further 17,253,500 Li Ning Shares on Open Market for about HKD 228,207,000; Stake to Rise to about 17.58%

Wed, 02 Sep 2026 13:36:40 GMT

NewTimeSpace News: On 2 September 2026, Viva Goods Company Limited (stock code: 00933.HK) announced that its wholly-owned subsidiary had on the same day acquired, through the Stock Exchange on the open market, a further aggregate of 17,253,500 shares of Li Ning Company Limited (stock code: 02331.HK), representing approximately 0.67% of the total issued shares of Li Ning as of the date of this announcement.
The total consideration for the acquisition is approximately HKD 228,207,000 (excluding stamp duty and related expenses), representing an average price of approximately HKD 13.23 per acquired share. The consideration was settled in cash in accordance with standard market practice, represented the prevailing market price of the acquired shares at the time of the acquisition and was funded by the Group's external financing. Completion of the acquisition will take place on the second trading day after instructions for the relevant acquisition are given.
Under the Listing Rules, as two of the applicable percentage ratios in respect of the acquisition exceed 5% but all are below 25% (calculated on an aggregated basis), the acquisition constitutes a discloseable transaction for the Company and is subject to the reporting and announcement requirements under Chapter 14 of the Listing Rules.
Prior to the acquisition, the acquirer held 437,156,543 Li Ning shares, representing approximately 16.91% of the total issued shares of Li Ning as of the date of this announcement; upon completion, it will hold 454,410,043 shares, representing approximately 17.58%. Li Ning will continue to be accounted for as an associate of the Group, which will continue to share in its profits less losses in its accounts.
As the acquisition was made through sellers on the open market via the Stock Exchange, the Company is not aware of the identity of the counterparties; based on all reasonable inquiries made by the directors, each seller and their respective ultimate beneficial owners are independent third parties. The Group is a multi-brand operator engaged mainly in the design and development, brand building and sale of sport and leisure apparel and footwear in the US, the UK, Europe, China, Japan and Korea. The directors consider the acquisition a suitable investment that enhances the Group's returns, entered into on normal commercial terms, fair and reasonable, and in the interests of the Company and its shareholders as a whole.

View announcement.

KEYTOP PARKING (02272.HK): Files Application for H-Share Full Circulation, Plans to Convert All 2,857,040 Unlisted Shares into H Shares on the Main Board

Wed, 02 Sep 2026 11:45:32 GMT

NewTimeSpace News: On 2 September 2026, KEYTOP PARKING INC. (stock code: 02272.HK) announced that it had filed an application with the China Securities Regulatory Commission (CSRC) on the same day to convert all of its 2,857,040 issued unlisted shares, with a par value of RMB 1.0 each, into H shares with a par value of RMB 1.0 each to be listed on the Main Board of the Stock Exchange of Hong Kong (the H-share full circulation).
The application was made pursuant to the Guidelines on Full Circulation of Unlisted Domestic Shares of H-share Companies, issued by the CSRC on 14 November 2019 and further amended on 10 August 2023. Upon obtaining all relevant approvals (including filing with and/or obtaining approval from the CSRC and the Stock Exchange) and complying with all applicable laws, regulations and rules, such unlisted shares will be converted into H shares, and the company will apply for approval for the listing of and dealing in such H shares on the Main Board of the Stock Exchange.
Under the company's articles of association, no further shareholders' meeting is required to approve the conversion and listing. As of the date of this announcement, details of the implementation plan for the conversion and listing have not yet been finalized, and the company will publish further announcements on progress in due course in accordance with the Listing Rules and the inside information provisions. Completion of the H-share full circulation and the conversion and listing is subject to the fulfillment of other relevant procedures required by the CSRC, the Stock Exchange and other relevant domestic and overseas regulators.

COFOE MEDICAL (01187.HK): Addresses Rationale for A-Share Buyback and H-Share Controlling Shareholder Increase; Seven Philips-Licensed Categories Gearing for Launch

Wed, 02 Sep 2026 11:34:49 GMT

NewTimeSpace News: On 2 September 2026, Cofoe Medical Technology Co., Ltd. (stock code: 01187.HK) published an overseas regulatory announcement setting out its investor relations activity record (No. 2026-007) posted on the Shenzhen Stock Exchange website and cninfo.com.cn. The record summarized the company's results briefing held the same day via an online session on the Panorama investor relations platform.
Regarding the strategic rationale for the A-share buyback and the H-share increase by the controlling shareholder, the company said the A-share buyback was its second this year and all repurchased shares would be cancelled, reducing total share capital and directly lifting key metrics such as earnings per share and return on equity while enhancing shareholders' interests; the controlling shareholder's concurrent H-share increase reflected confidence in the company's long-term development value and growth space in its core tracks. The company noted that its core product lines, including respiratory support, health monitoring and rehabilitation devices, are growing steadily, with innovations such as the C11 ventilator, continuous glucose monitoring system and Philips-launched products continuing to roll out.
On Philips cooperation, the company has obtained brand licensing from Philips for seven health monitoring categories in Greater China — blood glucose meters, blood pressure monitors, continuous glucose monitors (CGM), thermometers, pulse oximeters, spirometers and body weight scales — with the first batch of products having completed registration and certification as well as production line construction, and preparations for launch progressing. In addition, the company had approximately 15,000 shareholders in total as of 31 August 2026.

View announcement.

HAIXI PHARMA (02637.HK): Oral Retinal Disease Drug HX9428 Files Phase IIa IND for Diabetic Macular Edema; Phase I Data in nAMD Disclosed

Wed, 02 Sep 2026 11:32:38 GMT

NewTimeSpace News: On 2 September 2026, Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637.HK) announced that HX9428, a candidate molecule under its self-developed innovative drug program HXP056, submitted a Phase IIa investigational new drug (IND) application for diabetic macular edema (DME) to the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) on 31 August 2026, making DME the second indication being advanced for HX9428.
The Phase I dose-escalation study for the first indication, neovascular age-related macular degeneration (nAMD, also known as wet AMD), has been fully completed, enrolling 15 patients across five dose levels of 5-40 mg/QD. Of these, 13 patients (including 3 treatment-naive patients and 10 previously treated with anti-VEGF therapy) completed the planned 24 weeks of dosing without any additional intravitreal anti-VEGF injections; best-corrected visual acuity (BCVA) improved by more than 5 letters on average across the overall population, with the 3 treatment-naive patients improving by an average of 12 letters. Interim Phase I data as of February 2026 were published in the abstract of the 2026 American Academy of Ophthalmology (AAO) meeting, and HX9428 has received Fast Track Designation (FTD) from the US FDA, with Phase II studies in nAMD ongoing concurrently in China and the United States.
HX9428 is a novel oral small-molecule drug developed in-house for vascular retinal diseases including nAMD, DME and RVO. Current anti-VEGF therapy requires intravitreal injection, and oral administration is expected to offer patients a more convenient alternative. The company listed on the Main Board of the Hong Kong Stock Exchange in October 2025.

View announcement.

HK Stock Connect Daily Report: Biotech Stocks Shine; FTSE China 50 Adds Hua Hong Grace and Montage Technology - 20260902

Wed, 02 Sep 2026 11:10:47 GMT

I. Market Overview

On September 2, Hong Kong's three major indices declined across the board: the Hang Seng Index edged down 0.07% to 25,311.21 points, the Hang Seng TECH Index fell 0.74% and the Hang Seng China Enterprises Index shed 0.15%. Full-day turnover reached HKD 216.691 billion, contracting further from the previous trading day.

Biotech and pharmaceutical stocks stood out during the session: Biocytogen-B (02315) rose 11.52%, CStone Pharma-B (02616) gained 8.33% and Zai Lab (09688) added 5.45%. The property sector firmed, with China Overseas (00688) up 4.55% while Longfor Group fell 4.4%, showing divergence within the sector. Auto stocks were broadly under pressure: Li Auto-W (02015) hit a new low since its Hong Kong listing and XPeng-W (09868) fell 2.34%, with new-energy vehicle startups delivering divergent performance after August delivery figures were released. Non-ferrous metals traded weakly, with Zijin Mining (02899) down 1.7%. Power equipment stocks, PCB-related names and airline stocks also declined.

Southbound capital recorded net buying of HKD 4.093 billion on the day, of which the Shanghai leg of Stock Connect posted net buying of HKD 5.763 billion and the Shenzhen leg net selling of HKD 1.67 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Top Gainer 1	01686.HK	SUNEVISION	15.34	5.64	2.08
Top Gainer 2	02687.HK	ABLE DIGITAL	11.68	321.20	0.72
Top Gainer 3	02315.HK	BIOCYTOGEN-B	11.52	63.90	2.09
Top Gainer 4	02096.HK	SIMCERE PHARMA	7.64	11.83	1.71
Top Gainer 5	00668.HK	ANKER	6.73	134.80	1.26
Top Decliner 5	03939.HK	WANGUO GOLD GP	-7.13	14.72	10.92
Top Decliner 4	02652.HK	CF PHARMTECH	-7.97	12.70	0.24
Top Decliner 3	00268.HK	KINGDEE INT'L	-8.03	8.13	4.47
Top Decliner 2	09678.HK	UNISOUND	-9.14	77.55	3.01
Top Decliner 1	02718.HK	MININGLAMP-W	-9.23	49.20	2.79

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	00700.HK	TENCENT	57.00	3.36	-0.72
2	06869.HK	YOFC	39.76	2.88	3.23
3	00100.HK	MINIMAX-W	29.38	3.35	1.72
4	02513.HK	Z.AI	27.11	3.17	-5.26
5	09988.HK	ALIBABA-W	25.91	-7.65	-0.45
6	03690.HK	MEITUAN-W	20.34	0.99	2.74
7	01888.HK	KB LAMINATES	19.49	-1.55	3.29
8	00981.HK	SMIC	15.96	-2.62	-0.87
9	01299.HK	AIA	10.21	9.66	0.07
10	03308.HK	ZJ INNOLIGHT	8.82	4.52	0.19

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Top Gainer 1	159297	China Southern CNI HK Equities Innovative Drugs ETF	0.55	3.79
Top Gainer 2	520880	Hwabao WP Hang Seng HK Innovative Drugs Selected ETF	0.44	2.97
Top Gainer 3	159567	Yinhua CNI HK Equities Innovative Drugs ETF	0.43	7.01
Top Gainer 4	520690	Bosera Hang Seng HK Innovative Drugs Selected ETF	0.41	0.86
Top Gainer 5	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	0.34	3.79
Top Decliner 5	520600	GF CSI HK Equities Vehicles Industry Theme ETF	-2.87	1.61
Top Decliner 4	159028	Tianhong Hang Seng HK Equities Automobile Theme ETF	-3.01	0.12
Top Decliner 3	520780	Hwabao WP CSI HK Equities Vehicles Industry Theme ETF	-3.06	0.13
Top Decliner 2	520680	China Southern CSI HK Equities Vehicles Industry Theme ETF	-3.20	0.07
Top Decliner 1	159210	China Universal CSI HK Equities Vehicles Industry Theme ETF	-3.26	0.19

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	21.94	9.70	0.28
2	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	12.37	3.42	-1.05
3	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	11.33	51.66	-1.22
4	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	7.01	9.72	0.43
5	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	5.73	9.41	0.26
6	513190	ChinaAMC CSI HK Equities Interior Finance ETF	CSI HK Equities Interior Finance Index (HKD)	5.34	28.67	-0.95
7	526000	ChinaAMC CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (HKD)	5.04	240.31	-1.40
8	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	4.95	15.66	0.12
9	513750	GF CSI HK Connect Financials (ex Banks) Thematic ETF	CSI HK Connect Financials (ex Banks) Thematic Index (RMB)	4.68	3.72	-1.78
10	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	Hang Seng HK Equities Innovative Drugs And Health Care Index	4.60	13.86	0.23

IV. Industry and Corporate Updates

1. FTSE China 50 Quarterly Review: Hua Hong Grace and Montage Tech Added, Kuaishou-W and SF Holding Removed, Effective September 18

On September 2, FTSE Russell announced quarterly review changes to the FTSE China Index Series. FTSE China 50 will add Hua Hong Grace (01347.HK) and Montage Tech (06809.HK), and remove Kuaishou-W (01024.HK) and SF Holding (06936.HK); the changes will take effect after the market close on September 18. FTSE China 50 also released its reserve list for the new quarter, which includes China Coal Energy (01898.HK), CSC (06066.HK), Lens Technology (06613.HK), WuXi Biologics (02269.HK) and Yankuang Energy (01171.HK) among other Hong Kong-listed names. Hua Hong Grace and Montage Tech are both Stock Connect constituents.

2. NIO-SW Second-Quarter Revenue RMB 32.137 Billion, Up 69.1% Year on Year

On September 1, NIO-SW (09866.HK) reported its 2026 second-quarter results, with volume and price rising across its three brands. Total revenue reached RMB 32.137 billion in the quarter, up 69.1% year on year and 25.9% quarter on quarter; vehicle sales revenue stood at RMB 29.058 billion; adjusted net profit was RMB 26.1 million; the net loss narrowed sharply year on year to RMB 228 million; the gross margin was 18.4%; and the company held RMB 56.7 billion in cash. NIO is a potential Stock Connect constituent.

3. RiboLife-B Turned Profitable at the Interim as Revenue Surged 304%

On August 27, RiboLife-B (06938.HK) disclosed its 2026 interim results: revenue of RMB 420 million, up 304% year on year; net profit attributable to shareholders of RMB 20.3 million, swinging to a profit year on year; and cash and cash equivalents of RMB 2.24 billion at the end of the period. RiboLife was added to the Hang Seng Composite Index on August 21 and is expected to become a Stock Connect constituent.

4. Medcaptain's Public Offering Closed Today, Oversubscribed over 437 Times; Trading Expected to Commence September 7

On September 2, the public offering of Medcaptain (02041.HK), a medical device provider, closed at noon. According to reports, the public tranche drew preliminary subscriptions of 437.78 times, attracting around 58,000 applicants. The company plans a global offering of 38,910,600 H shares at an offer price of HK$15.42 per share, with a board lot of 100 shares and an application fee of about HK$1,557.55. Trading is expected to commence on September 7.

5. Haichang Ocean Park's First-Half Loss Widened; to Be Removed from Stock Connect from September 7

On September 2, Haichang Ocean Park (02255.HK) fell nearly 5% intraday, touching HK$0.213, a new low in more than five and a half years. The company's 2026 interim results showed first-half revenue of RMB 536 million, down 21.91% year on year, and a loss attributable to shareholders of RMB 332 million, widening 12.66% year on year. Under the Hang Seng Indexes Company's semi-annual index review, Haichang Ocean Park has been removed from the Hang Seng Composite Index; the change will be implemented after the close on September 4 and take effect from September 7, when the stock will also be dropped from Stock Connect.

V. Market Notes

Eligible securities list adjustment announcement

No recent announcements.

Trading calendar

No approaching market closure days.

HK shares ETFs Daily Report : Biotech & High-Dividend ETFs Edge Higher Modestly, Leveraged ChiNext, Korea and Taiwan ETFs Plunge - 20260902

Wed, 02 Sep 2026 10:11:03 GMT

NewTimeSpace News: On September 2, 2026, the HK shares ETFs market traded in an extremely depressed tone, with only 6 products posting gains, all within 1%, while leveraged ChiNext, Korea, Taiwan and Asia semiconductor ETFs plunged sharply across the board and market sentiment turned highly cautious.

Advancing products were extremely scarce during the session, with only 6 products posting gains, none exceeding 1%. E Fund (HK) Solactive Biopharma Select Index ETF (3186.HK) rose 0.82%, leading the gainers; CSOP Hang Seng Biotech ETF (3174.HK) added 0.70%; ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069.HK) gained 0.64%; Global X Hang Seng High Dividend Yield ETF (3110.HK) rose 0.58%; Samsung S&P High Dividend APAC ex NZ REITs ETF (3187.HK) edged up 0.12%; and HSI ESG Enhanced Select Index ETF (3136.HK) rose 0.07%. Overall, only biotech and high-dividend defensive names posted marginal gains, all within 1%, pointing to severely weak bullish appetite, with the number of advancing products hitting a recent low.

HK shares ETFs Top 10 Gainers
No.	Code	Name	Change (%)	Tracking Index	Manager
1	3186.HK	E Fund (HK) Solactive Biopharma Select Index ETF	0.82	--	E Fund Asset Management (Hong Kong) Limited
2	3174.HK	CSOP Hang Seng Biotech ETF	0.70	Hang Seng Hong Kong-Listed Biotech Index	CSOP Asset Management Limited
3	3069.HK	ChinaAMC Hang Seng Hong Kong Biotech Index ETF	0.64	Hang Seng Hong Kong-Listed Biotech Index	China Asset Management (Hong Kong)
4	3110.HK	Global X Hang Seng High Dividend Yield ETF	0.58	Hang Seng High Dividend Yield Index	Mirae Asset Global Investments (Hong Kong)
5	3187.HK	Samsung S&P High Dividend APAC ex NZ REITs ETF	0.12	S&P High Yield Asia Pacific ex New Zealand REIT Select Index	Samsung Asset Management (Hong Kong) Limited
6	3136.HK	HSI ESG Enhanced Select Index ETF	0.07	HSI ESG Enhanced Select Index	Hang Seng Investment Management
7	/	/	/	/	/
8	/	/	/	/	/
9	/	/	/	/	/
10	/	/	/	/	/
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 2, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

On the downside, leveraged ChiNext, Korea and Taiwan ETFs suffered sharp sell-offs, with many ETFs falling more than 3%. Bosera SZSE ChiNext Daily (2x) Leveraged Product (7234.HK) plunged 4.75%, the biggest decliner; CSOP KOSPI 200 Covered Call Active ETF (3537.HK) fell 3.53%; Global X Asia Semiconductor ETF (3119.HK) dropped 3.37%; Xtrackers MSCI Korea UCITS ETF (2848.HK) fell 3.33%; Phillip HK Newly Listed Equities Index ETF (2835.HK) declined 3.18%; iShares Core MSCI Taiwan Index ETF (3074.HK) lost 3.16%; CSOP SZSE ChiNext ETF (3147.HK) fell 3.02%; Premia FTSE TWSE Taiwan 50 ETF (3453.HK) dropped 2.96%; Global X Innovative Finance ETF (3185.HK) fell 2.89%; and Global X Japan Global Leaders ETF (3150.HK) declined 2.62%. Leveraged ChiNext, Korea, Taiwan, Asia semiconductor and fintech products faced concentrated selling pressure during the session, with all ten of the biggest decliners falling more than 2.6%.

HK shares ETFs Top 10 Decliners
No.	Code	Name	Change (%)	Tracking Index	Manager
1	7234.HK	Bosera SZSE ChiNext Daily (2x) Leveraged Product	-4.75	ChiNext Index (HKD) (CNH)	Bosera Asset Management (International)
2	3537.HK	CSOP KOSPI 200 Covered Call Active ETF	-3.53	--	CSOP Asset Management Limited
3	3119.HK	Global X Asia Semiconductor ETF	-3.37	ICE FactSet Asia Semiconductor Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
4	2848.HK	Xtrackers MSCI Korea UCITS ETF	-3.33	--	DWS Investment S.A.
5	2835.HK	Phillip HK Newly Listed Equities Index ETF	-3.18	Solactive Hong Kong Newly Listed Equities Index (Net Total Return)	Phillip Capital Management (Hong Kong) Limited
6	3074.HK	iShares Core MSCI Taiwan Index ETF	-3.16	MSCI Taiwan Index	BlackRock Asset Management North Asia Limited
7	3147.HK	CSOP SZSE ChiNext ETF	-3.02	ChiNext Index	CSOP Asset Management Limited
8	3453.HK	Premia FTSE TWSE Taiwan 50 ETF	-2.96	FTSE TWSE Taiwan 50 30% Capped Index	Premia Partners
9	3185.HK	Global X Innovative Finance ETF	-2.89	--	Mirae Asset Global Investments (Hong Kong)
10	3150.HK	Global X Japan Global Leaders ETF	-2.62	FactSet Japan Global Leaders Index (Net Total Return)	Mirae Asset Global Investments (Hong Kong)
Source/Compiled by: Wind / NewTimeSpace, as of the close onSeptember 2, 2026 Statistical note: Only HKD-denominated equity ETFs traded in the Hong Kong market are counted.

NewTimeSpace Research data show that on September 2, 2026, the HK shares ETFs market exhibited an extreme skew in which decliners far outnumbered gainers, with gains feeble and losses steep — rarely seen in recent sessions. Only 6 products posted gains, all within 1%, while leveraged ChiNext, Korea, Taiwan and Asia semiconductor ETFs slumped sharply in unison. The previous day's hotspots — Taiwan semiconductor and Korea plays — vanished quickly, leaving virtually no effective rallying theme. Biotech and high-dividend defensive products held up modestly but could not reverse the overall downturn, as regional technology sectors retreated across the board, market sentiment turned extremely subdued and sector rotation largely stalled.

NewTimeSpace

HK Newly Listed Stocks Weekly Tracker: AUX ELECTRIC's 1.3 Billion-Share Lock-up Expiry Lands Softly; UNISOUND Leads Rebound in Newer Listings - 20260904

I. Weekly Changes:UNISOUND Leads Gains; Two New Listings Fell over 20% in Debut Week

II. Review of Lock-up Expiries This Week:AUX ELECTRIC Released 1.3 Billion Shares and Fell 5.05% on the Week

III. Next Week's Lock-up Expiry Preview: Three Stocks, All of Small Size

IV. Liquidity Observations: MINIMAX-W's Average Daily Turnover Overtakes Z.AI

V. Deviation from IPO Price: DEEPZERO Extends Cumulative Gain to 1,599%; ZG GROUP-W Back to Deepest Discount

Matters to Watch Next Week

Going Global Weekly Report: Pharma Firms Sealed Licensing Deals at a Fast Pace as Semiconductors and E-Commerce Accelerate toward HK Listings - 20260904

Outbound M&A

Outbound Partnerships

Outbound Financing

Regulation and Compliance

Overseas Operating Data

NewTimeSpace Overseas Watch

HK Stock Connect Daily Report: PHANCY Surged Nearly 15%; Hang Seng Index Quarterly Review Effective Today, Goldman Sachs Expects USD 870 Million of Passive Inflows into Tech Hardware - 20260904

I. Market Overview

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

IV. Industry and Corporate Updates

V. Market Notes

TOYA receives CSRC supplementary information request on overseas listing filing, covering shareholding entrustment, controlling shareholder title disputes and equity incentives

GLB receives CSRC supplementary information request on overseas listing filing, covering absence of controlling shareholder, SOE procedures and proposed projects

NANJING LINGXING receives CSRC supplementary information request on overseas listing filing, covering absence of controlling shareholder, ride-hailing compliance and foreign investment access

UNIDT receives CSRC supplementary information request on overseas listing filing, covering capital contribution compliance, telecom licence and shareholder look-through

BBL HOME receives CSRC supplementary information request on overseas listing filing, covering shareholder look-through, foreign investment access and use of proceeds

Hong Kong AI Concept Stock Daily：Tesla Cybercab Officially Launched for Operation, Intelligent Driving Theme Generally Rose-20260904

BINHUI BIOPHARMA files for H-share listing and "full circulation" with CSRC filing, up to 38.10 million shares to be issued

AUTOLINK files for H-share listing and "full circulation" with CSRC filing, up to 68.26 million shares to be issued

KANGDA ENV (06136.HK): Completes Issuance of USD 50 Million 8.0% Senior Notes Due 2029

NewTimeSpace | Hong Kong Market Close: The three major indices opened higher and rebounded, with the Hang Seng Index closing up 1.74%, and themes such as media, industrial trade & commerce, and conglomerates led the gains

LONGSYS (09976.HK): Offer price fixed at HKD 236.00 per share, listing on 8 September

HK shares ETFs Daily Report : Fintech Surged Nearly 8%; Blockchain and Digital Technology Stocks Exploded Across the Board While China Little Giant ETFs Plunged Against the Trend - 20260904

HK shares ETFs Top 10 Gainers

HK shares ETFs Top 10 Decliners

EXCELLAND ROBOTICS (03231.HK): Public offering ends today with margin financing of HKD 4.214 billion, actual oversubscription of over 95 times

MEDCAPTAIN (02041.HK): Grey-market opens18.5% lower at HKD 12.59

Shanghai-Shenzhen Stock Connect ETFs Daily Report: Animal Husbandry ETFs Surged Over 4.5%; Media and Consumer Staples Rallied Broadly While Semiconductor Equipment Came Under Heavy Pressure Again - 20260904

Shanghai-Shenzhen Stock Connect ETF Top 10 Gainers

Shanghai-Shenzhen Stock Connect ETF Top 10 Losers

Autonomous Driving Concept Stocks Watch | XPENG-W (09868.HK) Trades Firm; Second‑Generation VLA Physical‑World Large Model Sees First Major Iteration

AI Chip Concept Stocks Watch | Hua Hong Grace (01347.HK) Slumped Sharply, Recently Announced Construction of a Wafer Foundry Line with Planned Monthly Capacity of 55,000 Wafers

Humanoid Robot Concept Stocks Watch | Midea Group (00300.HK) up 0.50%, Shenzhen unveils robot high-quality development plan

HONY MEDIA (00419.HK): Signs cooperation agreement with A-Living Smart Property Services on property robot operation platform

China Merchants CSI Animal Husbandry ETF (516670) latest price at RMB 0.63, CSI Animal Husbandry Industry Index (930707) up 2.48%

GF CSI Media Index ETF (512980) latest price at RMB 0.86, with shares outstanding up 294 million shares over the past week

GENSCRIPT BIO (01548.HK): Proposes spin-off and separate listing of Probio Technology on the Main Board

SALUBRIS files for listing on HKEX: the second largest in China by 2025 hospital sales of cardiovascular drugs, with innovative drugs accounting for over half of revenue

TENCENT MUSIC-SW (01698.HK): Prices USD 1 billion senior unsecured notes offering in two tranches

ASYMCHEM (06821.HK): 1,027,575 A-Share Restricted Shares under First Release Tranche of 2025 Incentive Plan to Become Tradable on September 7

CMS (00867.HK): China NDA Approval for Ruxolitinib Phosphate Cream in Atopic Dermatitis Adds a Second Indication

HK Stock Connect Daily Report: HUTCHMED Surged Over 14%, SHEIN-W Hit a Fresh Low, Baidu Inclusion Expectations Heat Up - 20260903

I. Market Overview

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

IV. Industry and Corporate Updates

V. Market Notes

Hong Kong AI Concept Stock Daily：Most AI chip and large-model names under pressure; Iluvatar CoreX (09903.HK) rose 9.23% against the trend-20260903

NewTimeSpace | Hong Kong Market Close: The three major indices opened higher but closed lower, with the Hang Seng Index ending down 0.39%, and themes such as non-ferrous metals and non-bank financials rising against the trend

HK shares ETFs Daily Report : Gold Miners Surged Nearly 4%; China Internet and Hang Seng TECH Came Under Pressure Again - 20260903

HK shares ETFs Top 10 Gainers

HK shares ETFs Top 10 Decliners

Autonomous Driving Concept Stocks Watch | BIDU-W (09888.HK) Edges Lower in Afternoon Session; MIIT Outlines Four Key Priorities for ICV & New‑Energy Vehicles in the 15th Five‑Year Plan

Shanghai-Shenzhen Stock Connect ETFs Daily Report: Gold Stock ETFs Led Strong Gains; STAR Semiconductors Pulled Back Moderately as Market Sentiment Recovered - 20260903

Shanghai-Shenzhen Stock Connect ETF Top 10 Gainers

Shanghai-Shenzhen Stock Connect ETF Top 10 Losers

LONGSYS (09976.HK): Public offering closed today, total margin financing of HKD 17.047 billion recorded

AI Chip Concept Stocks Watch | ASMPT (00522.HK) Up 2.67%; Broadcom Predicts AI Chip Sales to Surge Sharply

Humanoid Robot Concept Stock Watch | XIAOMI-W (01810.HK) Weakens Amid Volatility; Musk Predicts 1 Billion Humanoid Robots Globally Within a Decade

E.VAT MASTER files for listing on HKEX: the world's and China's largest cross-border e-commerce compliance service provider

Penghua CSI 800 Securities And Insurance ETF (515630) was last quoted at RMB 1.31, and the CSI 800 Securities And Insurance Index (399966) rose 1.91%

Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) was last quoted at RMB 2.22, and the CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity Index (931238) gained 2.02%